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INTRODUCTION 
 
Obesity, a chronic, relapsing, stigmatized, 
neurochemical disease that is more prevalent in 
developing/developed countries and leading to much 
comorbidity. Multiple factors are involved that contribute 
to the development of obesity.  These may be social, 
behavioural, environmental and genetic.  It is a global 
health problem in the present era.   
 
PATHOPHYSIOLOGY OF OBESITY 
 
Obesity is characterized by an increase in 
subcutaneous adipose tissue.  Its metabolic 
consequences, such as insulin resistance, are primarily 
attributable to increased fat deposition at sites such as the 
omentum, liver and skeletal muscles.     
 
Recently, a virus has been found to be associated 
with obesity.  Human adenovirus Ad-36 causes adiposity 
with obesity in animal models and enhances 
differentiation and lipid accumulation in human and 2T3-
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L1 pre-adipocytes, which may, in part, explain the 
adipogenic effect of Ad-36 (Srivastava et al. 2007).  
 
 
 
 
 
ROLE OF GENETICS IN OBESITY 
 
Genetics has shown tremendous effect on the 
process of weight gain.  Recent genetic studies have 
identified several different causative mutations underlying 
such syndromes.  The obesity gene map shows putative 
loci on all chromosomes except Y.  Around 176 human 
obesity cases due to single-gene mutations in 11 different 
genes have been reported, 50 loci related to mendelian 
syndromes relevant to human obesity have been 
mapped to a genomic region, and causal genes or strong 
candidates have been identified for most of these 
syndromes. 
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Inherited forms of obesity are syndromic and are 
result of abnormal functioning of single genes leading to 
weight gain.  About 30 mendelian disorders with obesity 
as a prominent feature, often are in association with 
mental retardation, dysmorphic features and organ-
specific developmental abnormalities have been 
identified which include mainly – Prader-willi, Bardet-Biedl 
syndrome, Albright’s hereditary osteodystrophy, Fragile X 
syndrome, Borjeson-Forssman-Lehmann Syndrome, Binge 
eating syndrome, Cohen syndrome, WAGR syndrome and 
Alstrom syndrome. 
 
The more common forms of obesity are however 
polygenic.  For most overweight people, obesity is a 
product of gene environment interaction. 
INSULIN AND INSULIN RECEPTOR GENE 
 
Insulin substrate-1 gene occupies key position in 
insulin signaling pathway.  After insulin binding to alpha 
subunit of insulin receptor, the beta subunit undergoes 
auto-phosphorylation and in turn phosphorylates other 
endogenous substrates in the cascade insulin action.  
Several polymorphisms have been identified in IRS-1 gene, 
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but Gly> Arg substitution at codon 972 is quite prevalent in 
Type II diabetes than in healthy controls.  The 
polymorphism has been associated with impaired glucose 
tolerance, this association has been more marked in 
obese subject (BMI > 25 kg/m2). 
 
ADIPONECTIN 
 
An adipocytokine encoded by APMI gene localized 
on chromosome 3q27 is one of the adipocyte-expressed 
proteins which regulate the homeostatic control of 
glucose, lipid and energy metabolism.  Evidences suggest 
its role in the genetic predisposition to metabolic X 
syndrome, such as insulin resistance, obesity, type 2 
diabetes, and coronary artery disease.   Adiponectin also 
enhances the transcription of other genes involved in fatty 
acid metabolism, most notably peroxisome proliferator-
activated receptor-α (PPAR-α).  It also contains response 
elements for PPAR-γ, a key regulator of glucose and lipid 
metabolism.  Evidences also suggest that adiponectin 
secretion is modulated by interleukins which may 
modulate fat, lean body composition and insulin 
sensitivity. 
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RESISTIN 
 
It is a cysteine-rich 12.5 kDa polyopeptide, 
adipocytokine, with a controversial history regarding its 
role in pathogenesis of obesity-mediated insulin resistance 
and type 2 diabetes mellitus.  The serum resistin 
concentration significantly correlates with the degree of 
obesity and distribution of fat.   
 
OTHER CANDIDATE GENES 
 
The SLC6A14 gene is an interesting novel candidate 
for obesity.  It encodes an amino acid transporter, which 
potentially regulates tryptophan availability for serotonin 
synthesis that possibly affects appetite control.  Interleukin-
1 receptor antagonist gene polymorphism has been 
found to be associated with higher BMI in north Indian 
population.   
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Berson and Yalow defined insulin resistance (IR) as a 
state (of a cell, tissue, system, or body) in which greater 
than normal amount of insulin is required to elicit a 
quantitatively normal response (Gupta et al. 2004).  
Resistance to insulin is an important risk factor in the 
industrial world and is often associated with obesity.  Apart 
from its effect on the carbohydrate metabolism, insulin has 
diverse functions to perform in other body systems 
(Mohan, 2005). 
 
Although insulin resistance is characterized by cells 
becoming less sensitive to the effects of insulin to transport 
glucose into cells, insulin insensitivity does not seem to 
lower the growth promoting properties of insulin. Only the 
glucose transporting properties are affected in insulin 
resistance.  Thus, in an insulin resistant state, such as 
induced by obesity, the higher circulating levels of insulin 
may have a cancer-promoting influence for at least some 
tissues. As long as the pancreas can continue to produce 
large amounts of insulin in the face of insulin resistance, 
some individuals may avoid diabetes; however, these 
individuals may be the ones most susceptible to cancer 
because they have the highest circulating insulin 
concentrations. 
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 FIGURE 1 
Furthermore, obesity associated with increased 
incidence of type 2 diabetes mellitus, hypertension, 
coronary heart disease, arthritis, sleep apnea, and certain 
forms of cancer.  Several obesity-related cancers, 
including breast, prostate, endometrium, colon and 
gallbladder cancer, have a hormonal basis and are life 
style-related.  Breast cancer is the most frequent cancer 
and the second leading cause of cancer death among 
women.  Excess adiposity over the pre- and post-
menopausal years is an independent risk factor for the 
development of breast cancer, and is also associated 
with late-stage disease and poor prognosis (Yu Wang et 
al. 2007).  
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 Breast cancer (BC) is one of the most important 
problem of public health.  The inability to effectively 
predict, prevent, and treat metastatic breast cancer is a 
major problem in breast cancer care.  One factor that 
may impact survival outcome is obesity (Lorincz et al. 
2006).  The risk of breast cancer is traditionally linked to 
obesity in postmenopausal women; conversely, it is neutral 
or even protective in premenopausal women.  Since the 
initiator and promoter factors for breast cancer act over a 
long time, it seems unlikely that the menopausal transition 
may have too big an impact on the role of obesity in the 
magnitude of the risk.  
 
 
 
 
POSSIBLE MECHANISMS OF BREAST CANCER RISK AND 
OBESITY 
 
• Reduced detection of tumour, late diagnosis 
• Increased free bioactive estrogen levels* 
• Increased androgen levels* 
• Increased extraglandular conversion of androgens to estrogens 
• Decreased steroid hormone binding globulin 
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• Increased growth factors (i.e. insulin-like growth factor*) 
• Increased receptors for growth factors 
• Decreased specific binding proteins for growth factors 
• Hyperinsulinaemia 
• Increased insulin resistance 
• Elevated non-esterified fatty acids 
• Increased lipid-soluble carcinogens, especially in the breast* 
*-  Mechanisms with direct involvement in mammary carcinogenesis 
 
OBESITY AND ENDOGENOUS SEX STEROIDS 
 
Obesity has been associated with lower levels of sex 
hormone-binding globulin (SHBG) and plasma total and 
bioavailable androgens and estrogens.  Sex steroids are 
mitogens that can stimulate cell proliferation, inhibit 
apoptosis, and therefore potentially increase the chance 
of malignant cell transformation, particularly of 
endometrium and breast but possibly also at other organ 
sites (eg, prostate-, colorectal cancer). 
 
Several mechanisms may link obesity with the level of 
sex steroids.  First, insulin and IGF-I stimulate the synthesis of 
sex steroids in ovarian, testicular or adrenal tissue, and 
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inhibit the hepatic synthesis of SHBG, increasing their free 
circulating levels and bioavailability to tissues.  The 
increased production of androgen from the ovarian 
thecal cells and possibly from the adrenal gland leads to 
anovulatory cycles and lower progesterone levels. This 
syndrome, named polycystic ovary syndrom (PCOS), is a 
metabolic disorder also associated with insulin resistance.  
It has been related to a higher risk for endometrial cancer.  
Finally, adipocytes express sex hormone metabolising 
enzymes and are the main site of estrogen production in 
postmenopausal women.  Obese women show higher 
aromatization of androgenic precursors to estrogens with 
BMI positively correlated with circulating sex-hormone 
levels (Ceschia et al. 2007). 
 
As adipose tissue mass increases circulating 
concentrations of insulin and IGF-I, blood concentrations 
of SHBG begin to diminish.  In one study, obese women 
(BMI >30 kg/m2) had an average SHBG concentration 
that was half that of women with a BMI of <22 kg/m2 
(McTiernan et al. 2003).  SHBG binds testosterone and 
estradiol with high affinity.  A decrease in SHBG in obesity 
results in an increase in the bioavailable fraction of 
circulating estradiol.  In postmenopausal women, breast 
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cancer risk has been shown to be directly related to 
concentrations of various sex hormones, including estrone, 
total estradiol, and bioavailable estradiol, while blood 
levels of SHBG are inversely correlated with breast cancer 
risk (Jacquotte et al. 2004). 
 
POTENTIAL MECHANISMS FOR THE INFLUENCE OF TYPE 2 
DIABETES ON THE RISK OF BREAST CANCER 
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FIGURE 2 
OBESITY – CANCER 
 
 
FIGURE 3 
In obesity, increased release from adipose tissue of 
free fatty acids (FFA), tumour-necrosis factor- (TNF) and 
resistin, and reduced release of adiponectin lead to the 
development of insulin resistance and compensatory, 
chronic hyperinsulinaemia.  Increased insulin levels leads 
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to reduced liver synthesis and blood levels of IGFBP1.  
Increased fasting levels of insulin in the plasma are 
generally also associated with reduced levels of IGFBP2 in 
the blood.  This results in increased levels of bioavailable 
IGF1.  Increased levels of serum IGF1 have been found to 
be related to increased risk of breast cancer, especially 
among premenopausal women.  Insulin and IGF1 signal 
through the insulin receptors (IRs) and IGF1 receptor 
(IGF1R), respectively, to promote cellular proliferation and 
inhibit apoptosis in many tissue types. These effects might 
contribute to tumorigenesis. 
 
OBESITY, HORMONES AND ENDOMETRIAL CANCER 
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 FIGURE 4 
Obesity can increase the risk of endometrial cancer 
through several parallel endocrine pathways. Obesity is 
associated with increased insulin levels, which lead to 
increases in IGF1 activity and an increased androgen 
production by the ovaries.  This inhibits ovulation (chronic 
anovulation), which leads to progesterone deficiency.  
Increased adiposity also increases aromatase activity, 
leading to increased levels of bioavailable estrogen levels 
in postmenopausal women.  Estrogens increase 
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endometrial cell proliferation and inhibit apoptosis, 
partially by stimulating the local synthesis of IGF1 in 
endometrial tissue.  Among premenopausal women, the 
lack of progesterone, because of ovarian androgen 
production and continuous anovulation, leads to reduced 
production of IGFBP1 by the endometrium.  After 
menopause (and in the absence of exogenous estrogen 
production), when ovarian progesterone synthesis has 
ceased altogether, the more central risk factor seems to 
be obesity-related increases in bioavailable estrogen 
levels.  In addition to estrogens and progesterone, insulin 
itself could also promote endometrial cancer 
development by reducing concentrations of sex-
hormone-binding globulin (SHBG) in the blood, which 
would increase the levels of bioavailable estrogens that 
can diffuse into endometrial tissue. 
 
Metabolic syndrome, also known as insulin resistance 
syndrome, consists of a cluster of conditions such as abdominal 
obesity, high blood glucose levels, impaired glucose tolerance, 
abnormal lipid levels and hypertension.    
Obesity, type 2 diabetes and the metabolic syndrome also have 
in common an increased production of leptin and a decreased 
production of adiponectin by adipose tissue, with consequent 
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elevations and reductions, respectively, in the circulating levels of 
these two adipokines.  Adiponectin is a key molecule mediating 
insulin resistance in obesity (Kadowaki et al. 2003).  These changes in 
plasma leptin and adiponectin, acting through endocrine and paracrine 
mechanisms, have been associated in several studies with an increase 
in breast cancer risk and, to more aggressive tumours.  Studies in vitro 
showed that leptin stimulates, and adiponectin inhibits, tumour cell 
proliferation and the microvessel angiogenesis which is essential for 
breast cancer development and progression (Davis et al (2007).  
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S. NO 
HORMONE OR 
BINDING 
GLOBULIN 
OBESITY VS NORMAL WEIGHT 
1 Insulin Increased levels with obesity 
2 IGF 1 Non-linear relation, with peak 
levels in people with BMI of 
24-27 kg/m2. 
3 Free IGF 1 Increased levels with obesity 
4 IGFBP1 Decreased levels with obesity 
5 IGFBP3 Increased levels with obesity 
6 SHBG Decreased levels with obesity 
7 Total testosterone Increased levels with obesity 
(premenopausal women with 
PCOS) 
8 Free testosterone Increased levels with obesity 
9 Total estradiol Increased with obesity in 
postmenopausal women  
10 Free estradiol Increased levels with obesity 
in postmenopausal women 
Results and Discussion  
  
A Study on Insulin Resistance and Obesity among Women 
at High Risk for Breast Cancer Using Cluster Analysis 
31 
11 Progesterone In premenopausal – 
decreased levels with obesity 
with a susceptibility to 
develop ovarian 
hyperandrogenism. 
 
 
 
 
MOLECULAR MECHANISMS SUPPORTING THE LINK BETWEEN 
OBESITY AND BREAST CANCER 
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FIGURE 5 
Three mechanisms are thought to contribute to the 
association between type 2 diabetes and breast cancer: 
activation of the insulin pathway, activation of the insulin-
like-growth-factor pathway, and impaired regulation of 
endogenous sex hormones (Ido Wolf et al. 2005). 
Adipose tissue has been shown to be an important 
player in obesity-related mammary carcinogenesis. 
Results and Discussion  
  
A Study on Insulin Resistance and Obesity among Women 
at High Risk for Breast Cancer Using Cluster Analysis 
33 
Adiponectin suppresses obesity-related mammary 
tumorigenesis via multiple mechanisms: 
 
FIGURE 6 
Adipocyte is one of the predominant stromal cell 
types in the microenvironment of mammary tissue.  It is 
also the major site for local estrogen production from 
androgens by aromatase, thus contributing to the 
development of estrogen-dependent breast cancer in 
postmenopausal women.  Low levels of adiponectin in 
insulin resistance suggest that therapeutic modulation of 
adiponectin may provide a novel treatment for insulin 
resistance as well (Kaur et al. 2005).  Additionally, the 
increased fat mass is associated with aberrant insulin 
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signaling (insulin resistance) and increased insulin levels, 
which could directly stimulate mammary carcinogenesis.   
 
INCREASED ESTROGEN IN OBESE POSTMENOPAUSAL 
WOMEN 
In obese post-menopausal women, adipose tissue of 
the breast, abdomen, thighs, and buttocks are the main 
sites of estrogen biosynthesis, with levels of aromatase 
increasing with age and BMI.  In fact, local estrogen levels 
in breast tumors are as much as 10 times greater than in 
the circulation of postmenopausal women.  This is 
presumably due to tumor–adipocyte interactions that 
stimulate the increased production of aromatase.  Other 
factors, such as tumor necrosis factor a (TNF-a) and 
interleukin (IL)-6, are secreted by adipocytes and act in an 
autocrine or paracrine manner to stimulate production of 
aromatase. 
  
Insulin resistance leads to high plasma insulin 
concentrations, which activate the extracellular-related-
kinase (ERK) and the AKT pathways through activation of 
the insulin receptor (IR) or the insulin-like-growth-factor-1 
(IGF-1) receptor.  High expression of the insulin receptor in 
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breast cancer augments activation of these pathways.  
Diabetes is associated with reduced adiponectin plasma 
levels, which inhibits the AMP kinase (AMPK) and activates 
the ERK and Akt pathways in breast cancer cells.  
Diabetes increases production of sex 
hormones and deceases sex hormone binding globulin 
(SHBG) production, leading to high plasma free estrogen 
concentrations, which in turn activate the estrogen 
receptor (ER).  Activation of these 
pathways can lead to proliferation, invasiveness, 
angiogenesis and decreased apoptosis (Ido Wolf et al. 
2008). 
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FIGURE 7 
The link between the insulin resistance hormones, IGF-I, 
IGFBP-3 and C-peptide, a positive energy balance, and breast cancer 
risk is that higher levels of visceral fat result in a compensatory 
response of resistance to the insulin-stimulated glucose uptake in the 
peripheral tissues.  The overabundance of insulin, called 
hyperinsulinemia, amplifies the bioavailability of IGF-I. IGFI and 
insulin together have been shown to stimulate motility in human 
breast cancer cell lines (Alecia Malin Fair et al. 2007). 
 
 
OBESITY AND BODY FAT DISTRIBUTION 
 
Obesity and body fat distribution are major determinants of sex 
hormone-binding globulin (SHBG).  The sex hormone-binding 
globulin levels decrease substantially with increasing levels of obesity 
among postmenopausal women.  The degree of obesity, the amount of 
intra-abdominal fat, and the waist-to-hip ratio have all been related to 
the increased risk of breast cancer.  The levels of SHBG and any 
relationship to breast cancer may, therefore, be only a measure of the 
degree of obesity and the high correlation with levels of sex hormone-
binding globulin. 
 
FAT DISTRIBUTION, SEX HORMONES AND BREAST 
CANCER RISK 
 
Results and Discussion  
  
A Study on Insulin Resistance and Obesity among Women 
at High Risk for Breast Cancer Using Cluster Analysis 
37 
Hormone levels are greatly influenced not only by total fat mass 
but more significantly by fat distribution.  The decreased synthesis of 
SHBG in overweight and obese women is predominantly linked to 
visceral obesity and associated with hyperinsulinaemia.  In post-
menopausal women the incidence of obesity increases and is often 
centrally distributed.  This is in turn linked to higher levels of 
estrogens produced from androgens in the adipocyte and decreased 
estrogen–protein binding due to the reduction in SHBG, leading to 
higher bioavailable estrone and 17-β-estradiol.  Increased levels of 
bioavailable androgens are also linked to a central fat distribution and 
increase breast cancer risk directly through increasing breast cancer 
cell proliferation after binding to androgen receptors, in addition to 
their influence on insulin sensitivity.  There is also strong evidence 
that insulin is the central regulating factor for hepatic SHBG 
production and has been shown to inhibit the production of SHBG in 
liver cells.  There is also relatively strong evidence that elevated 
plasma concentrations of insulin are related to lower SHBG levels in 
obese women. 
 
The severity of obesity is estimated from the total 
amount of fat and the fat distribution in the human body.  
In clinical practice, more simple methods are used, such 
as the weight - height tables, the Body Mass Index (BMI) 
assessment and the skin fold measurement.  The weight - 
height tables, which are published in many different 
versions, indicate an acceptable weight range for a 
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particular height, different between men and women, 
beyond which, a person is defined as either underweight 
or overweight.  The main disadvantage in using them, is 
the fact that it is not possible to distinguish between fat 
and muscle percentage.  Consequently, a very muscular 
person is possible to be described by such a table as 
obese. 
 
The body mass index (BMI), or Quetelet index, is a 
controversial statistical measurement which compares a 
person's weight and height.  BMI is a very common, easy 
and reliable way to classify patients into groups and 
compare them.  Although there is a high correlation 
between BMI and fat percentage, it does not provide 
information about the weight of the muscle tissue and 
bones.  BMI is a mathematical formula that is defined by 
dividing the body weight to the second power of the 
height:  
 
BMI = Body Weight (Kg) / height2 (m2) 
 
BODY FAT MASS 
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Skin- fold measurements technique is the simplest 
method for measuring body fat percentage and the 
results are obtained according to specific tables.  Waist 
Circumference (WC) provides important information 
about the accumulation and distribution of the body fat. 
More specifically, it is considered an adequate tool for 
assessing central obesity.  Also, the ratio of Waist to Hip 
(WHR) is another easy method for assessing central 
obesity.  WHR is defined as the ratio between the lower 
part of the crest of the iliac ala and the perimeter of the 
hips, measured at the level of trochanters. 
Body fat % = BFW x 100 
       TBW 
Body fat weight (BFW) = TBW – LBM 
LBM = Factor 1 + ((factor 2 +factor 5) – (factor 3 
+factor 4)) 
Factor 1 = TBW x 0.732) + 8.987 
Factor 2 = Wrist circumference 
    3.140 
Factor 3 = Waist circumference x 0.157 
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Factor 4 = Hip circumference x 0.249 
Factor 5 = Forearm circumference x 0.434 
 
APPLICATIONS: 
 
1. BMI is also used as a measure of underweight, owing 
to advocacy on behalf of those suffering with eating 
disorders, such as anorexia nervosa and bulimia 
nervosa 
2. BMI can be calculated quickly and without 
expensive equipment. 
 
LIMITATIONS: 
 
1. Because the BMI is dependent only upon weight and 
height, it makes simplistic assumptions about 
distribution of muscle and bone mass, and thus may 
overestimate adiposity on those with more lean 
body mass (e.g. athletes) while underestimating 
adiposity on those with less lean body mass (e.g. the 
elderly). 
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2. Loss of height through aging. In this situation, BMI will 
increase without any corresponding increase in 
weight. 
 
 
 
MEASUREMENT OF INSULIN RESPONSE 
 
The gold standard for measuring hyperinsulinemic 
clamp technique, while that for measuring the response of 
β-cell to glucose is the hyperglycemic clamp technique.  
However, such complicated and time consuming 
procedures are not convenient for clinical use and thus 
more simple methods are recommended for 
epidemiological studies. 
Results and Discussion  
  
A Study on Insulin Resistance and Obesity among Women 
at High Risk for Breast Cancer Using Cluster Analysis 
42 
 
FIGURE 8  
The oral glucose tolerance test (OGTT) 
recommended by WHO is the most widely used for 
estimation of whole-body glucose tolerance in vivo.  
However, a large number of subjects with normal glucose 
levels during OGTT shows abnormal insulin sensitivity.  To 
predict the risk of development of insulin resistance and 
type 2 diabetes mellitus in such subjects, several insulin 
sensitivity indices as calculated from plasma glucose and 
plasma insulin concentrations during OGTT were 
proposed.  The values correlated closely with the insulin 
sensitivity as defined by the euglycemic clamp method 
(Cervenakova et al. 2002).  
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In this study, various insulin sensitivity indices derived 
from the concentrations of insulin and glucose during 
fasting state and during OGTT in subjects with normal 
glucose tolerance were calculated and compared with 
respect to their relationship with body mass. 
 
The major role of the insulin sensitivity indices are 
1. To predict the development of diabetes mellitus 
Type 2 in healthy population and in individuals with 
impaired glucose metabolism. 
2. To assess the degree of insulin sensitivity in non-
diabetic population with risk factors present. 
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DISPOSITION INDEX 
 
GRAPH 1 
 
 The importance of expressing β-cell responsivity 
in relation to insulin sensitivity is illustrated by using the 
disposition index metric; i.e., the product of β -cell 
responsivity and insulin sensitivity is assumed to be a 
constant.  A normal subject reacts to impaired insulin 
sensitivity by increasing β -cell responsivity (state II), 
whereas a subject with impaired tolerance does not (state 
2).  In state II, β -cell responsivity is increased but the 
disposition index β -cell metric is normal, whereas in state 
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2, β-cell responsivity is normal but the disposition index is 
impaired. 
 
 
HOMEOSTASIS MODEL (HOMA) 
 
 The homeostasis model assessment (HOMA) 
represents the simplest model for evaluating insulin 
sensitivity and secretion.  This model was based on the 
assumption that normal-weight healthy subjects aged < 
35 years have an insulin resistance of 1 and β-cell function 
of 100%.  HOMA calculates insulin resistance and β-cell 
function from fasting glucose (nmol/l) and insulin (mIU/l) 
concentrations.  The formulas represent an approximation 
to the HOMA, where IRHOMA stays for the insulin resistance. 
 
 IRHOMA =   I0 x G0 
   22.5 
The ability to easily assess insulin sensitivity would 
therefore be useful for investigating the role of insulin 
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resistance in the pathophysiology of these diseases 
(Soonthornpun et al. 2002). 
  
Homeostasis model assessment (HOMA) proposed by 
Matthews et al. (1985) is based on the relationship 
between insulin and glucose concentrations during fasting 
state.  The IRHOMA correlated well with insulin resistance as 
measured by euglycemic clamp. 
 
 
 
CEDERHOLM INDEX 
 
The insulin sensitivity index proposed by Cederholm 
and Wibell (1990) represents mainly peripheral insulin 
sensitivity and muscular glucose uptake, due to the 
dominant role of peripheral tissues in glucose disposal 
after an oral glucose load. 
 
ISICederholm=75000 +(G0- G120) x 1.15 x 180 x 0.19x BW 
120 x log (Imean) x  Gmean 
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Where 75000 -  oral glucose load in an OGTT (75000 mg) 
 G0 - fasting plasma  glucose  concentration 
(mmol/l) 
G120 - plasma glucose concentration in the 120 
min of     OGTT(mmol/l) 
1.15 - factor transforming whole venous blood 
glucose to plasma valuses 
180 - conversion factor to transform plama 
glucose concentration from mmol/l into mg/l. 
 0.19 - glucose space in liter per kg of body 
weight 
 BW - body weight (kg) 
 Imean - mean plasma insulin concentration during 
OGTT (mU/l) 
Gmean - mean glucose concentration during 
OGTT (mmol/l) 
 
GUTT INDEX 
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This index was adapted from the insulin sensitivity 
index proposed by Cederholm and Wibell (1990).  It is 
expressed in mg.l2.mmol-1.mIU-1.min-1.   
 
ISI0,120 = 75000 + (G0 – G120) x 0.19 x  BW 
    120 x Gmean x log (Imean) 
Where 75000  -  oral glucose load in an OGTT (75000 
mg) 
 G0  - fasting plasma  glucose  
concentration (mmol/l) 
G120  - plasma glucose concentration in the 
120 min of OGTT(mmol/l) 
          0.19  - glucose space in liter per kg of body 
weight 
 BW  - body weight (kg) 
 Imean  - mean plasma insulin concentration 
during OGTT (mIU/l) 
 Gmean - mean glucose concentration during 
OGTT (mmol/l) 
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STUMVOLL INDEX 
 
Stumvoll et al. proposed a series of indices 
calculated from plasma glucose and insulin 
concentrations during OGTT.  The equations were 
generated using the multiple linear regression analysis and 
adapted to the availabilities of sampling times during 
OGTT and demographic parameters (BMI, age).   
 
ISIStumvoll = 0.222 – 0.00333 x BMI -0.0000779 x I120 –   
0.000422 x Age 
 
BMI  - Body mass index (kg/m2) 
 
In the overweight group the insulin sensitivity indices 
were lower ISIStumvoll, ISICederholm, ISIMatsuda and insulin 
resistance index IR HOMA was higher.  BMI correlated 
inversely with insulin sensitivity indices  and the correlation 
was highest in ISIMatsuda, followed by ISI Cederholm and ISI Stumvoll.  
The indices of insulin secretion were in positive relationship 
with BMI and the AUC ins showed better correlation than 
Secr HOMA. 
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ADVANTAGES: 
 
There are many mathematical models to detect 
insulin resistance or insulin sensitivity. It would be helpful if 
one can evaluate insulin resistance or sensitivity in a 
clinical setting. This can help select the most appropriate 
candidates for insulin-sensitising drugs and subsequent 
planning of interventions. 
 
 
EQUATIONS OF INSULIN SENSITIVITY INDICES  
S.NO INDEX EQUATION 
1 FASTING 
INSULIN-1 
1/INS0 
2 FASTING 
GLUCOSE 
TO INSULIN 
RATIO 
GLU0/INS0 
3 HOMA IR IG/22.5 
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4 RAYNAUD 40/INS0 
5 BELFOIRE(F) 2/IG+1 
6 FIRI-1 1/I x G/22.5 
7 QUICKI 1/LOG I /LOG G 
8 INS120-1 1/1NS120 
 
9 
 
CEDERHOLM 
75000 +(fasting glucose-2-h glucose) x1.15 
x180 x 0.19xBW 
120 x log (mean insulin) x mean glucose 
 
10 
 
MATSUDA 
 
_________________10,000___________________ 
√(fasting glucose x fasting insulin) x (mean glucose x 
mean insulin) 
11 GUTT 75000 + (G0 – G120) x 0.19 x  BW 
      120 x Gmean x log (Imean) 
12 Stumvoll 0.22-0.0032 x BMI – 0.0000645 x 2-h insulin -
0.0037 x 1.5- h glucose 
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RISK FACTORS FOR BREAST CANCER 
 
A. PERSONAL                 B. FAMILY              C. MEASURABLE       
    HISTORY                              HISTORY                 PARAMETERS 
                                                                                    
i. Developmental         i.  Cancer                              i.  
Physical  
 a. Life time events     ii.  Other genetic defects        ii.  
Biochemical  
 b. Pregnancy   iii.  Hormones 
    related events   iv.  Imaging 
    v.  Cells 
ii. Diseases  
  a. Surgery 
  b. Cancer 
 
iii.  Lifestyle  
  a. Emotional 
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  b. Behavioural 
  c. Work-related 
 
 
 
 
 
 
A. PERSONAL HISTORY 
i.  Developmental  ii. Diseases   iii.  Lifestyle 
  a. Lifetime events            a. Surgery                  a. Emotional 
   1. Age at menarche          1. Biopsies                    1. Stress 
   2. Age at first life birth    2. Radiation exposure   2. 
Personality 
   3. Age at menopause       3. HRT                           
   4. Parity/ Nulliparity  
 
 b. Pregnancy related        b. Cancer                    b.  
Behavioural 
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    i. Nausea/vomitting         i. Ovarian    i. Smoking 
   ii. Induced abortion          ii. Pancreatic                ii. 
Alcohol 
  iii. GDM                           iii. ADH                     
  iv. Weight gain                 iv. ALH                   c.  Work- 
related 
  v. Pre-eclampsia      v.  LCIS                    i.  Type of  
  vi. High birth weight occupation 
  vii. Synthetic estrogens 
 
B. FAMILY HISTORY 
   
i.  Cancer    ii. Other genetic defects 
   1. No of cancer cases          
   2. Relationship (1º, 2 º, 3 º)     
   3. Age at cancer               
 
 
C. MEASURABLE PARAMETERS 
Results and Discussion  
  
A Study on Insulin Resistance and Obesity among Women 
at High Risk for Breast Cancer Using Cluster Analysis 
56 
a.  Physical 
    1. BMI → Height, weight 
    2. Waist circumference 
    3. Hip circumference 
    4. WHR 
    5. Wrist circumference 
    6. Forearm circumference 
    7. Percent body fat 
 
b.  Biochemical 
1. Aromatase 
2. POMC peptides 
3. IL-6 
4. IL-1 ß 
5. Lipids/ triglycerides/ cholesterol 
6. Tumour- infiltrating lymphocytes 
7. Adiponectin 
8. Insulin 
9. IGF-1 
10. IGF-2 
11. Leptin 
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12. C-peptide 
13. IGFBP-3 
14. NEFA 
15. Fructosamine 
     
c.  Hormones 
1. Estradiol-free E2, non- SHBG bound E2, SHBG bound E2,, 
total E2 
2. Estrone 
3.  Estriol 
4. SHBG (↓) 
5. Testosterone- free T 
6. DHEA (S) 
7. Androsterone (↓) 
8. Etiocholanolone (↓) 
9. Androstenedione 
10. Prolactin 
11. LH 
12. FSH 
13. Progesterone 
14. CBG 
 
c.  Imaging 
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1. Mammogram 
2. MRI 
3. Elastography 
4. Breast ultrasound 
5. Ductogram 
6. Scinti-mammography 
7. Tomosynthesis 
 
e.  Cells 
1. Breast cells 
2. Bone Mineral Density 
3. Breast density 
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DRUGS FOR BREAST CANCER TREATMENT 
ANDROGENS 
 
Calustserone Epitiostanol  Testolactone 
 Testosterone  Propionate 
Dromostanolone Mepitiostane 
 
ANTIADRENALS 
Aminoglutethimide Exemestane    Formestane        
Vorozole 
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ANTI-ESTROGENS 
Droloxifene  Tamoxifen  Toremifene 
 Exemestane 
 
ANTIPROGESTINS 
Onapristone  
 
AROMATASE INHIBITORS 
Aminogluethimide  Exemestane 
 Formestane       Vorozole 
Anastrozole   Fadrozole  Letrozole
 Acolbifene 
 
ESTROGENS 
Diethylstilbestrol Hexestrol Estradiol Ethinylestradiol  
Fosfestrol Polystradiol PO4 
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LH-RH ANALOGS 
Buserilin Goserilin  Triptorelin Cetorelix 
 
PROGESTOGENS 
Chlormadinone Medroxy  Megestrol Acetate      
Melengesterol 
Acetate  Progesterone Hydroxyprogesterone 
 
MONOCLONAL ANTIBODIES 
Herceptin 
 
AROMATASE INHIBITORS: 
 
 There are two types of aromatase inhibitors namely 
1. Irreversible steroidal activators and  
2. Reversible nonsteroidal imidazole-based inhibitors. 
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FIGURE 9 
Breast cancer cell growth may be estrogen-
dependent.  Aromatase is the principal enzyme that 
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converts androgens to estrogens both in pre- and 
postmenopausal women.  While the main source of 
estrogen (primarily estradiol) is the ovary in 
premenopausal women, the principal source of 
circulating estrogens in postmenopausal women is from 
conversion of adrenal and ovarian androgens 
(androstenedione and testosterone) to estrogens (estrone 
and estradiol) by the aromatase enzyme in peripheral 
tissues.  Estrogen deprivation through aromatase inhibition 
is an effective and selective treatment for some 
postmenopausal patients with hormone-dependent 
breast cancer. 
AROMATASE INHIBITORS 
 
EXEMESTANE 
Mechansim of Action:  Exemestane is an 
irreversible, steroidal aromatase inactivator, structurally 
related to the natural substrate androstenedione.  It acts 
as a false substrate for the aromatase enzyme, and is 
processed to an intermediate that binds irreversibly to the 
active site of the enzyme causing its inactivation, an 
effect also known as “suicide inhibition.”  Exemestane 
significantly lowers circulating estrogen concentrations in 
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postmenopausal women, but has no detectable effect on 
adrenal biosynthesis of corticosteroids or aldosterone.  
Exemestane has no effect on other enzymes involved in 
the steroidogenic pathway up to a concentration at least 
600 times higher than that inhibiting the aromatase 
enzyme. 
 
SIDE EFFECTS:  Hot flashes, nausea, fatigue, 
increased appetite, joint pain and muscle pain, hair loss, 
hypertension, insomnia, increased sweating, vision 
problems, arm or leg pain. back pain, arthritis, dizziness, 
abdominal pain (or stomach pain), diarrhea, flu symptoms 
(such as fever or chills), swelling or water retention, 
constipation. 
 
 
 
 
LETROZOLE 
MECHANISM OF ACTION:  Letrozole is a non-steroidal 
competitive inhibitor of the aromatase enzyme system; it 
inhibits the conversion of androgens to estrogens.  
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Letrozole selectively inhibits gonadal steroidogenesis but 
has no significant effect on adrenal mineralocorticoid or 
glucocorticoid synthesis.  Letrozole inhibits the aromatase 
enzyme by competitively binding to the heme of the 
cytochrome P450 subunit of the enzyme, resulting in a 
reduction of estrogen biosynthesis in all tissues.  Treatment 
of women with letrozole significantly lowers serum estrone, 
estradiol and estrone sulfate and has not been shown to 
significantly affect adrenal corticosteroid synthesis, 
aldosterone synthesis, or synthesis of thyroid hormones. 
 
SIDE EFFECTS:  Musculoskeletal pain, nausea, head 
ache, joint pain, fatigue, difficulty in breathing, muscle 
pain, constipation, diarrhea, drowsiness and joint pain 
 
ANASTROZOLE 
MECHANISM OF ACTION:  Anastrozole is a potent 
and selective non-steroidal aromatase inhibitor.  It 
significantly lowers serum estradiol concentrations and has 
no detectable effect on formation of adrenal 
corticosteroids or aldosterone  
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SIDE EFFECTS:  Hot Flashes, asthenia, arthritis, pain, 
arthralgia, pharyngitis, hypertension, depression, nausea 
and vomiting, rash, osteoporosis, fractures, back pain, 
insomnia, pain, headache, bone pain, peripheral edema, 
increased cough, dyspnea, pharyngitis and lymphedema. 
 
AMINOGLUTETHIMIDE 
MECHANISM OF ACTION:  It inhibits the enzymatic 
conversion of cholesterol to Δ5-pregnenolone, resulting in 
a decrease in the production of adrenal glucocorticoids, 
mineralocorticoids, estrogens, and androgens and blocks 
several other steps in steroid synthesis, including the C-11, 
C-18, and C-21 hydroxylations and the hydroxylations 
required for the aromatization of androgens to estrogens, 
mediated through the binding of aminoglutethimide to 
cytochrome P-450 complexes. 
 
SIDE EFFECTS:  The most frequent and reversible side 
effects were drowsiness, morbilliform skin rash, nausea and 
anorexia, and dizziness. The dizziness was possibly caused 
by lowered vascular resistance or orthostasis. 
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ANDROGENS 
 
TESTOLACTONE   
Mechanism of Action:  Inhibition of steroid 
aromatase activity and consequent reduction in estrone 
synthesis from adrenal androstenedione, the major source 
of estrogen in postmenopausal women.  Based on in vitro 
studies, the aromatase inhibition may be noncompetitive 
and irreversible. 
 
Side Effects:  Maculopapular erythema, increase 
in blood pressure, paresthesia, malaise, aches and edema 
of the extremities, glossitis, anorexia, and nausea and 
vomiting.  Alopecia alone and with associated nail growth 
disturbance have been reported rarely; these side effects 
subsided without interruption of treatment. 
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ANTI-ESTROGENS 
 
FARNESTON 
 
MECHANISM OF ACTION:  Binds to estrogen 
receptors on breast cancer cells, preventing the cells from 
growing and dividing. 
 
SIDE EFFECTS:  Hot flashes, nausea, weight gain, 
allergic reactions like skin rashes and headache. 
 
FULVESTRANT: 
 
MECHANISM OF ACTION:  Fulvestrant is an estrogen 
receptor antagonist that binds to the estrogen receptor in 
a competitive manner with affinity comparable to that of 
estradiol.  It downregulates the ER protein in human breast 
cancer cells.  It exerts its action by blocking the binding of 
estrogens to the estrogen receptor in all tissues, thereby 
causing generalized estrogen deprivation. 
 
Results and Discussion  
  
A Study on Insulin Resistance and Obesity among Women 
at High Risk for Breast Cancer Using Cluster Analysis 
69 
SIDE EFFECTS:  Gastrointestinal symptoms (including 
nausea, vomiting, constipation, diarrhea and abdominal 
pain), headache, back pain, vasodilatation (hot flushes), 
and pharyngitis. 
 
MONOCLONAL ANTIBODIES 
 
HERCEPTIN 
MECHANISM OF ACTION:  Herceptin attaches to the 
protein receptor on the surface of breast cancer cells.  By 
binding to the cells, herceptin slows the growth and 
spread of tumors that have an overabundance of HER2 
protein receptors. 
 
SIDE EFFECTS:  Weakening of the heart muscle, 
reduction of white blood cells, diarrhea, anemia and 
abdominal pain or infection. 
 
 
MEGESTROL 
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MECHANISM OF ACTION:  Pharmacologic doses of 
megestrol exerted a direct cytotoxic effect on human 
breast cancer cells in vitro and proved capable of 
modifying and abolishing the stimulatory effects of 
estrogen on breast cancer cell lines.  Megestrol interacts 
with progesterone receptors to stimulate cell maturation 
through a progestin-inducing mechanism.  It has also 
been shown to have certain androgenic properties and 
may also modify glucocorticoid action by binding to the 
glucocorticoid receptor.  
 
SIDE EFFECTS:  Changes in appetite, thirst or weight, 
diarrhea, constipation, frequent urination, swelling of 
ankles or feet, increased rate or difficulty breathing or 
some loss of scalp hair, vaginal bleeding or discharge, 
severe or sudden vision changes, headache, loss of 
coordination, slurred speech, trouble breathing, weakness 
or numbness in arms or legs, skin rash or itching. 
 
LH-RH ANALOGUES 
 
GOSERELIN 
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MECHANISM OF ACTION:  It binds to LHRH receptors 
on pituitary gland cells and form clusters, which are then 
sequestered within the cell, thereby reducing the number 
of unoccupied LHRH receptors.  These unoccupied 
receptors are maintained at low levels by the presence of 
the LHRH analogue, ultimately resulting in reduced LH 
secretion.  In turn, the reduced plasma LH causes a 
decrease in circulatory estradiol (the main source of 
estrogen in premenopausal women) to levels comparable 
to the postmenopausal state within 21 days, which are 
maintained with continued administration of LHRH 
analogues. 
 
SIDE EFFECTS:  Rarely, hypersensitivity reactions 
(including urticaria and anaphylaxis), Changes in blood 
pressure, manifest as hypotension or hypertension, ovarian 
cyst formation have been reported. 
 
ANTI-ESTROGENS 
 
RALOXIFENE 
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MECHANISM OF ACTION:  The biological actions of 
raloxifene are largely mediated through binding to 
estrogen receptors. This binding results in activation of 
certain estrogenic pathways and blockade of others. 
Thus, raloxifene is an estrogen agonist/antagonist, 
commonly referred to as a selective estrogen receptor 
modulator (SERM). 
 
SIDE EFFECTS:  Hot flashes, sweating, or leg cramps 
may occur.  Raloxifene may infrequently cause serious 
blood clots to form in the legs, lungs, or eyes, leg 
swelling/pain, trouble breathing, chest pain and vision 
changes 
TAMOXIFEN 
MECHANISM OF ACTION:  Tamoxifen citrate is a 
nonsteroidal agent that has demonstrated potent 
antiestrogenic properties due to its ability to compete with 
estrogen for binding sites in target tissues such as breast.  
Tamoxifen inhibits the induction of rat mammary 
carcinoma induced by dimethylbenzanthracene (DMBA) 
and causes the regression of already established DMBA-
induced tumors. In this rat model, tamoxifen appears to 
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exert its antitumor effects by binding the estrogen 
receptors 
 
SIDE EFFECTS:  Hot flashes, irregular mensrual cycles, 
unusual vaginal discharge or bleeding, irritation of skin 
around vagina. 
 
TOREMIFENE 
MECHANISM OF ACTION:  Toremifene is a 
nonsteroidal triphenylethylene derivative.  Toremifene 
binds to estrogen receptors and may exert estrogenic, 
antiestrogenic, or both activities, depending upon the 
duration of treatment, animal species, gender, target 
organ, or endpoint selected.  The antitumor effect of 
toremifene in breast cancer is believed to be mainly due 
to its antiestrogenic effects, ie, its ability to compete with 
estrogen for binding sites in the cancer, blocking the 
growth-stimulating effects of estrogen in the tumor. 
 
SIDE EFFECTS:  Hot Flashes, Sweating, Nausea, 
Vaginal Discharge, Dizziness, Edema, Vomiting, Vaginal 
Bleeding. nausea and vomiting, fatigue, thrombophlebitis, 
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depression, lethargy, anorexia, ischemic attack, arthritis, 
pulmonary embolism, and myocardial infarction). 
 
 
FIGURE 10 
Both oestradiol and tamoxifen bind to the estrogen receptor 
(ER) and lead to dimerization, conformational change in the activating 
function-2 (AF2) domain of ER and binding to estrogen-response 
elements (EREs). The conformational change with tamoxifen is 
different from that with oestradiol and leads to persistent but less 
efficient transcription of most estrogen-dependent genes. Estrogen 
depletion leads to an absence of estrogen-dependent transcription. 
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REVIEW OF LITERATURE 
 
Malita FM et al. (2009) made a study to compare the 
relationship between several insulin sensitivity indices with 
cardiometabolic risk factors in overweight and obese 
postmenopausal women.  They concluded that the 
different methods of measuring and/or expressing insulin 
sensitivity display variations for associations with 
cardiometabolic risk factors.  Therefore interpretations of 
relationships between insulin sensitivity indices and 
cardiometabolic risk factors should take into account the 
method used to estimate and express insulin sensitivity. 
 
Montazeri et al. (2008) examined the relationship 
between anthropometric variables and risk of breast 
cancer in post-menopausal women.  He reported that 
weight gain might be a better measure of adult obesity 
than BMI or body fat mass or fat free mass components of 
BMI are found to be more discriminant factors for breast 
cancer incidence risk than the commonly used BMI. 
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Wang et al. (2007) demonstrated for the first time 
that adiponectin could modulate the GSK3β/β-catenin 
pathway in human breast cancer cells, which might play 
a critical role in mediating the inhibitory effects of 
adiponectin on mammary tumorigenesis.  Further 
suggested that the cross-talks between adipokines and 
Wnt signaling pathways might represent a critical 
mechanism underlying the development of obesity-
related cancers. 
 
Lorincz et al. (2006) recognized the need to identify 
and alter the modifiable breast cancer risks mainly 
focusing on obesity.  He summarized that maintenance of 
a lean body mass offers a way in which women can 
modestly to significantly reduce their relative breast 
cancer risk.  He concluded that examination of pathways 
that are altered in obesity may offer new targets for breast 
cancer therapy. 
 
Kaur et al. (2005)  suggested that higher BMI is 
associated with a more advanced stage of breast cancer 
at diagnosis. Further  investigated the relationship 
between indicators of body size and breast cancer 
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incidences. Studies on attained height in relation to breast 
cancer occurrence from diverse populations consistently 
suggested that taller women are a greater risk for breast 
cancer regardless of menopausal status.  
 
Wolf et al. (2005) reported that incidence of both 
breast cancer and type 2 diabetes is high in elderly 
people and both share a common risk factor—obesity.   
He proposed that three mechanisms contribute to the 
association between type 2 diabetes and breast cancer: 
activation of the insulin pathway, activation of the insulin-
like-growth-factor pathway, and impaired regulation of 
endogenous sex hormones. 
Calle et al. (2004) explained the mechanisms relating 
adiposity to cancer risk.  His study indicated that the 
relationship between BMI and breast cancer can be 
explained by the adiposity-related increase in 
endogenous estrogen levels. 
 
Gupta et al. (2004) made a study to evaluate 
surrogate markers of insulin resistance in forty euglycemic 
healthy subjects.  The surrogate markers were significantly 
correlated to MCR and found that there was no significant 
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superiority of one marker over the other. Finally, they 
suggested that measuring insulin levels alone in a single 
fasting sample can serve as a simple, cheap and 
convenient indirect qualitative index of IR. 
 
McTiernan et al. (2003) studied the association 
between BMI, body fat mass and percent body fat with 
concentration of estrone, estradiol, testosterone, SHBG, 
DHEA, free estradiol and free testosterone.  He reported 
that obese women (BMI > 30) had 35% high concentration 
of estrone and 130% higher concentration of estradiol 
compared with lighter-weight women (BMI <22).  He 
further indicated that overall amount of body fat may be 
more important than distribution of body fat in 
determining sex hormone concentrations in post-
menopausal women with breast cancer.  
 
Soonthornpun  et al. (2003)  attempted to develop a 
new equation that is more suitable than others in assessing 
insulin sensitivity in subjects with normal glucose tolerance.  
They tested the hypothesis that equation for ISIOGTT derived 
from the area above the glucose curve correlated with 
ISIClamp, and the degree of correlation was stronger than 
that of other previously reported ISIOGTT. 
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Takashi Kadowaki  et al., 2003  endeavored to 
depict the molecular mechanism of insulin resistance, 
focusing on the function of adipocyte.  The study 
provided the first direct evidence that adiponectin plays a 
protective role against insulin resistance and 
atherosclerosis in vivo. These observations clearly 
indicated that adiponectin is indeed an insulin-sensitizing 
hormone and exerts a protective role against insulin 
resistance in vivo.  It is evident from the preceding results 
that PPARγ  is a key molecule to mediate high-fat-diet 
induced obesity and that depression of adiponectin 
action have crucial roles in insulin resistance induced by 
obesity.  He confirmed that replenishment of adiponectin 
represents a novel treatment strategy for insulin resistance 
and Type II diabetes. 
 
Radikova et al. (2003) evaluated critically the use of 
some of the proposed indices in  insulin sensitivity 
estimation- indices calculated using fasting plasma 
concentrations of insulin, glucose and triglycerides and 
indices calculated by using plasma concentrations of 
insulin and glucose obtained during 120 min of a standard 
OGTT. 
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 Stoll et al. (2002) showed that long continued insulin 
resistance was associated with upper abdominal adiposity 
can lead to aberrant insulin signalling through the insulin 
receptor 1 pathway in the cell.  The evidence pointed to 
a mechanism by which upper abdominal obesity and 
associated insulin resistance may increase the risk of 
breast cancer in women. 
  
Zofia Cervenakova  et al. (2002) made a study to 
evaluate the influence of body composition on various 
indices of insulin sensitivity and secretion in subjects with 
normal glucose tolerance. The results showed that all 
subjects had a normal glucose tolerance and no 
difference was found in course of glycemia, while 
overweight subjects had an enhanced insulin response.   
In overweight individuals the insulin sensitivity indices were 
found to be significantly increased.  It was finally 
concluded that the easiest way to predict insulin 
resistance in normal glucose tolerance is to calculate an 
index from glucose and insulin concentration during an 
OGTT. 
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Stumvoll et al. (2000) evaluated to what extent insulin 
sensitivity and insulin release are interdependent.  He 
predicted metabolic clearance rate of glucose and 
insulin sensitivity index for 104 non-diabetic volunteers from 
their OGTT values.  He concluded that it is possible to 
obtain an individual ’s insulin sensitivity and β-cell function 
from BMI and values for plasma glucose and insulin 
obtained during an OGTT. 
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MATERIALS AND METHODS 
 
• Xylene-manufactured by Fischer Chemic Ltd., 
• Sterile  Absorbent Cotton-manufactured by The 
Ramaraju Surgical Cotton Mills Ltd., 
• Sterile blood lancets-manufactured by Medipoint, 
Inc., 
• Blood glucose test strips- manufactured by Major 
Biosystem Corp.  
• Glucose-D-(1 kg)-manufactured by Avalon Cosm. 
Pvt. Ltd., 
• Centrifuge- Eppendorf Ltd., 
• Centrifuge tubes (1 ml)- Eppendorf Ltd., 
• Disposable syringe (5 ml)-BD 
• Vaccum blood collection tube (5ml)- manufactured 
by peerless biotech private ltd., 
• Disposable filler-BD 
• Precision pipettes and tips, 0.05 ml, 0.1 ml – Tarsons 
Products Pvt. Ltd., 
• Disposable pipette tips- Himedia 
• Distilled water 
• Absorbent paper  
• Microtiter plate reader- Tarsons Products Pvt. Ltd., 
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• Monoclonal anti Insulin antibody coated microtiter 
plate with 96 wells. 
• Enzyme conjugate reagent, 12 ml. 
• Insulin reference standards containing; 0, 5, 25, 50, 
100, and 200 uIU/ml. lyophilized 0.5mlx2sets. 
• Wash Solution Concentrate, 50X, 15ml 
• Chemiluminescence Reagent A, 6.0 ml. 
• Chemiluminescence Reagent B, 6.0 ml. 
• Body measurement table 
• Toledo self-zeroing weight scale 
• Steel measuring tape 
• Small sliding caliper 
 
REAGENTS FOR INSULIN ASSAY: 
 
1. All reagents were kept at room temperature (18-
25°C) and mixed gently by inverting or swirling 
without formation of foam. 
2. 1 volume of Wash Buffer (50x) was diluted with 49 
volumes of distilled water 
3. Each lyophilized standard was reconstituted with 0.5 
ml of distilled water and was allowed to stand for 20 
minutes. 
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INSTRUMENT: 
OGTT   -  Gluco Chek blood glucose 
monitoring  
system- manufactured by Major 
Biosystem Corp Taiwan 
INSULIN ASSAY  - Immulite 2000 
Vortex mixer  - Remi Motors Ltd.,  
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METHODOLOGY 
 
PRINCIPLE FOR ANTHROPOMETRIC MEASUREMENTS: 
 
Anthropometry is the study of the measurement of 
the human body in terms of the dimensions of bone, 
muscle, and adipose (fat) tissue.  Measures of 
subcutaneous adipose tissue are important because 
individuals with large values are reported to be at 
increased risks for hypertension, adult-onset diabetes 
mellitus, cardiovascular disease, gallstones, arthritis, and 
other disease, and forms of cancer. 
  
Anthropometric measurements such as skinfolds and 
circumferences and bioelectrical impedance (a method 
used to estimate the amount of lean tissue) will allow 
cross-sectional analysis of the relationship between 
obesity and risk of disease.  Body measurements are 
always taken on the right side of the body.  All 
measurements, except skinfolds, should be taken to the 
nearest tenth of a centimeter or 1.0 millimeter.  Skinfold 
measurements are taken to the nearest 0.1 millimeter.   
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1.  WEIGHT: 
 
The electronic digital scale was adjusted to kilogram 
mode and the digital LED readout showed “0” before 
weighing a sampled person. 
If it does not, adjust on the keyboard scale to zero the 
scale.  The sampled person stood on the center of the 
weight scale platform and the weight was recorded in 
kilograms in the automated system. 
  
2. STANDING HEIGHT 
 
The sampled person (SP) stood erect on the floor 
with her back to the vertical backboard as the weight of 
the participant should be evenly distributed on both feet.  
The heels of the feet were placed together with both 
heels touching the base of the vertical board. The feet 
should be pointed slightly outward at a 60 degree angle. 
If the SP has knock knees, the feet should be separated so 
that the inside of the knees are in contact but not 
overlapping. The buttocks, scapulae, and head were 
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positioned in contact with the vertical backboard.  The 
arms were positioned to hang freely by the sides of the 
trunk with palms facing the thighs. 
  
The SP was asked to inhale deeply and to stand fully 
erect without altering the position of the heels. The SP’s 
head was maintained in the Frankfort Horizontal Plane 
position. Hair ornaments, buns, braids, etc. were removed 
to obtain an accurate measurement. 
 
 
 
3.  FOREARM CIRCUMFERENCE 
 
The SP stood with the elbow relaxed so that the right 
arm hangs freely to the side.  The measuring tape was 
placed around the upper arm at the marked point 
perpendicular to the long axis of the upper arm (from 
upper arm length). The tape was again held so that the 
zero end is held below the measurement value. The tape 
should rest on the skin surface, but not pulled tight enough 
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to compress the skin. The arm circumference was 
recorded to the nearest 0.1 cm. 
 
4.  ABDOMINAL (WAIST) CIRCUMFERENCE 
 
The examiner stood behind the SP and palpate the 
hip area for the right iliac crest and a horizontal line was 
marked at the high point of the iliac crest and then made 
to cross the line to indicate the midaxillary line of the 
body.  Then the waist circumference was measured 
without compressing the skin.  The measurement was 
made at minimal respiration to the nearest 0.1 cm. 
 
5.  BUTTOCKS (HIP) CIRCUMFERENCE 
 
The SP was made to stand erect with feet together 
and weight evenly distributed on both feet. The 
measurement was taken by placing the measuring tape 
around the buttocks. The tape was placed at the 
maximum extension of the buttocks. The zero end of the 
tape was held under the measurement value.  
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6. WRIST BREADTH 
 
The SP was made to extend the right arm keeping 
the arm straight and near the side of the chest.  The most 
prominent aspect of the ulnar styloid process was 
palpated with the middle finger of the right hand and the 
right blade of the caliper was made to slide on to this 
landmark. The most prominent aspect of the radial styloid 
process was located with the middle finger of the left 
hand. Firm pressure was then applied and the breadth 
was recorded to the nearest 0.1 cm.  
 
Methodology for cluster analysis  
Data obtained often fall naturally into groups / 
clusters, of observations, where the characteristics of 
objects in the same cluster are similar.  We further stratified 
the population using a software program and performed 
clustered analysis.     
 
K-means clustering (partitioning) treats observations 
in the data as objects having locations and distances 
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from each other. It partitions the objects into K mutually 
exclusive clusters, such that objects within each cluster are 
as close to each other as possible, and as far from objects 
in other clusters as possible. Each cluster is characterized 
by its centroid (center point). Of course, the distances 
used in clustering often do not represent spatial distances.  
Hierarchical clustering investigates grouping in the data, 
simultaneously over a variety of scales of distance, by 
creating a cluster tree. The tree is not a single set of 
clusters, as in K-Means, but rather a multi-level hierarchy, 
where clusters at one level are joined as clusters at the 
next higher level. This allows us to decide what scale or 
level of clustering is most appropriate in our application.   
 
Variables were analyzed by a computer program 
which permits direct visualization of the three dimensional 
shape of the data set and the subjects were classified by 
means of a computer classification which employed a 
cluster analysis technique.  This resulted in the definition of 
three groups.                                                                                                         
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ORAL GLUCOSE TOLERANCE TEST 
 OGTT 
 
Fasting        glucose load 
(75g) 
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(Done at 8.30 a.m after 10-12 hrs  (Done after 
half-an-hour  overnight fasting)        
 from fasting)  
                                    
Blood  collection by                     Blood 
collection by  
finger prick method                                                finger prick 
method 
                                                                                     
Collection of blood                                 Sample collection 
of blood at  
 sample at 0 min                                 30, 60, 90, 120 min 
respectively 
                                                                                         
Blood glucose monitoring                      Blood glucose 
monitoring 
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PRINCIPLE FOR INSULIN ASSAY 
 The Insulin Quantitative Test Kit is based on a solid 
phase enzyme-linked immunosorbent assay. The assay 
system utilizes one anti-Insulin antibody for solid phase 
(microtiter wells) immobilization and another anti-Insulin 
antibody in the antibody-enzyme (horseradish peroxidase) 
conjugate solution. The standards and test specimen 
(serum) are added to the Insulin antibody coated 
microtiter wells. Then anti- Insulin antibody labeled with 
horseradish peroxidase (conjugate) is added. If human 
Insulin is present in the specimen, it will combine with the 
antibody on the well and the enzyme conjugate resulting 
in the Insulin molecules being sandwiched between the 
solid phase and enzyme-linked antibodies. After  1 hour 
incubation at room temperature, the wells are washed 
with water to remove unbound labeled antibodies. A 
solution of chemiluminescent substrate is then added and 
read relative light units (RLU) in a Lumino meters. The 
intensity of the emitting light is proportional to the amount 
of enzyme present and is directly related to the amount of 
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insulin in the sample. By reference to a series of insulin 
standards assayed in the same way, the concentration of 
insulin in the unknown sample is quantified. 
 
 
 
 
 
 
I.  OGTT: 
 Currently two methods are available: 
 a.  Traditional Method- Finger Prick Method 
 b.  Glucose Oxidase Method 
 
a.  TRADITIONAL METHOD: 
 Blood glucose meter is a small portable machine 
used to monitor blood glucose levels. 
 
PROCEDURE: 
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1. Hands were washed in warm, soapy water and dried 
thoroughly. 
2. Finger tip was cleansed using sterile cotton soaked in 
spirit 
3. The finger was then allowed to dry. 
4. The test strip was inserted into the slot of the glucose 
meter with the black bars of the test strip facing up. 
5. Fingertip was pricked using a sterile lancet and gently 
squeezed to get a drop of blood. 
6. The blood drop was placed on the test strip, previously 
inserted into the glucose meter and monitored for 
blood glucose levels. 
7. The glucose meter soon displays the blood glucose 
level as a number in mg/dl unit. 
 
 
 
INSULIN ASSAY 
PROCEDURE FOR SERUM COLLECTION 
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1. A tourniquet was placed around the upper arm to 
apply pressure and cause the veins to swell with 
blood. 
2. Blood was drawn from a vein in the arm inside of the 
elbow after cleaning the skin surface with an 
antiseptic and collected in a syringe. 
3. The blood was then collected in a plain red-top 
venipuncture tube without additives. 
4. The blood was then allowed to clot. 
5. The specimen was then centrifuged to separate the 
serum from cells. 
 
INSULIN ASSAY PROCEDURE 
 
1. Desired number of coated wells  were secured in the 
holder. 50μl of Insulin standards, specimens, and 
controls were added into the appropriate wells and 
mixed gently for 10 seconds. 
2. 100μl of enzyme conjugate reagent was added into 
each well and mixed gently for 30 seconds to 
facilitate complete mixing and incubated at room 
temperature for 60 minutes. 
3. The incubation mixture was then removed and the 
microtiter plate was rinsed 5 times with 1 x wash 
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buffer (300μl each well). Then the residual water 
droplets were removed using absorbent paper. 
4. 100 μl Chemiluminescence substrate solution  was 
then added into each well and gently mixed for 5 
seconds. 
5. After 5 minutes, the wells were observed using a 
chemiluminescence microwell reader.  
 
METHODOLOGY FOR CALCULATING HOMA-IR 
Homeostasis model assessments of insulin resistance 
(HOMA2-IR) and pancreatic beta-cell function (HOMA2-
%B) were completed using the HOMA Calculator version 
2.2.2 (http://www.dtu.ox.ac.uk, accessed Feb 2010). 
 
INDICES CALCULATION 
  The indices evaluated were selected a priori based 
on their performance in previous investigations.The insulin 
sensitivity index (ISI) was calculated from the oral glucose 
tolerance test according to the formula:  ISI = 10,000 ÷ √ 
([fasting plasma glucose × fasting plasma insulin] × [mean 
OGTT glucose × mean OGTT insulin]).  
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Beta-cell function was assessed as corrected 
incremental insulin response (CIR) during the glucose-
tolerance test according to the formula:  
CIR = (100 × insulin at 30 min) ÷ ([glucose at 30 min] × 
[glucose at 30 min − 3.89])  (or)  as a disposition index (i.e., 
insulin secretion adjusted for insulin sensitivity, or CIR × ISI). 
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OBJECTIVE 
 
 To stratify the female population based on their 
obesity and body fat distributions using cluster 
analysis without relating to conventional obesity cut-
off values. 
 
 To study insulin response (sensitivity x resistance) using 
indices of surrogate measures obtained from OGTT 
data. 
 
 To identify the hormonal parameters that are 
significantly altered in obese breast cancer patients 
and to exploit them as screening markers along with 
body mass index (BMI) and body fat mass (BFM). 
 
 To build a comprehensive questionnaire for breast 
cancer risk prediction using related variables and the 
symptoms associated with hormonal variations in 
breast cancer. 
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PURPOSE OF STUDY 
 
According to estimates of the International Obesity 
Task Force, 1,7 billion people are exposed to health risks 
related to body weight, while the increase in Body Mass 
Index (BMI) is responsible for more than 2.5 million deaths 
annually, which is expected to double by 2030. The aim is 
to define obesity using anthropometric measures 
particularly in obese post-menopausal women. 
 
Assessment of insulin resistance is of great 
importance in the study of epidemiology and 
pathophysiology of major public health problems and in 
following the clinical course of patients on various 
therapeutic regimens. It is also of our interest to evaluate 
the insulin resistance in obese post-menopausal women 
who are at high risk for breast cancer using a simple oral 
glucose tolerance test (OGTT). 
 
Studying about relevant risk factors of breast cancer 
and their prevalence is essential in the breast cancer risk 
prediction among individuals of high risk group. 
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RESULTS AND DISCUSSION 
We measured the anthropometric measurements for 
70 female individuals and obtained the measurements of 
height, weight, circumferences of wrist, forearm, waist and 
hip.  
TABLE 1  
CODE AGE 
HT 
(m) 
TBW 
(kg) 
WRIST 
(cm) 
FOREARM 
(cm) 
WAIST 
(cm) 
HIP 
(cm) 
1 35 1.52 40 5.9 8.5 26.5 33.8 
2 25 1.472 42 5.5 8.4 31.8 33.5 
3 24 1.575 55 6 9 31 38.3 
4 24 1.665 61 6 8.9 35.2 41 
5 24 1.528 46.5 6.1 9.1 29 35.1 
6 30 1.55 63.5 6.5 9.8 35 41.6 
7 38 1.58 68.5 6.9 10.2 37 41.8 
8 24 1.55 43 5.4 7.9 27 35.1 
9 25 1.6 66 6.1 9.6 40.8 42.3 
10 21 1.57 43 5.5 8.4 26.5 33.5 
11 24 1.64 49 5.6 8.2 27 34.9 
12 24 1.66 55 5.9 9 30 39.3 
13 25 1.58 43 5.4 8 28 35 
Results and Discussion  
  
A Study on Insulin Resistance and Obesity among Women 
at High Risk for Breast Cancer Using Cluster Analysis 
102 
14 28 1.61 50 5.6 8.8 30 38.5 
15 23 1.45 42 5.4 8.4 26 32.9 
16 23 1.67 54 5.2 8.1 29.5 37.9 
17 30 1.57 76 6.3 10.9 44 45.5 
18 23 1.656 41 5.3 7.8 29 34.5 
19 30 1.615 56 6.4 9.6 35.3 42 
20 22 1.615 50 6.1 8.5 32.8 36.2 
21 47 1.478 76 7 11.4 45 48.5 
22 39 1.56 40 5.8 8.5 31.6 33 
23 21 1.5 65 6.4 10 39.8 43.5 
24 20 1.59 35 5.1 7.6 27.2 32.1 
25 21 1.568 50 5.8 8.9 32.8 35.5 
26 21 1.564 39 5.6 8.3 29.2 33.8 
27 20 1.502 42 6.4 8.9 30.6 34.1 
28 25 1.543 52 5.9 9 32 39.3 
29 23 1.668 40 7.8 7.9 30.2 33.2 
30 28 1.472 41 6 8.9 31.8 34 
31 22 1.57 46 5.8 8.4 35.3 36 
32 20 1.536 47 6 9 32.5 36.8 
33 19 1.578 43 6.1 8.6 30.1 33 
34 18 1.617 47 6.1 9 31.5 33.8 
35 21 1.525 45.5 5.8 8.9 31.9 34.8 
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36 26 1.57 49 5.8 8.5 32 36 
37 20 1.563 42.5 6 8.5 30.7 33 
38 21 1.612 51 6.2 8.8 34.3 35.5 
39 29 1.59 56.5 6 10.1 35.8 38.8 
40 42 1.582 47 5.6 8.8 34 35.3 
41 26 1.54 75 7.5 10.6 42.8 42 
42 25 1.42 44 5.7 8.5 34.5 36 
43 28 1.603 40 5.2 7.9 32 34.3 
44 50 1.48 50 6.2 8.9 37.8 39.8 
45 65 1.457 45 6.3 9 36.9 35.5 
46 40 1.478 45.5 6.2 8.8 33 36 
47 37 1.507 45.5 6.8 9.3 35 34.2 
48 27 1.538 54.5 6.6 9.1 39 38.8 
49 35 1.485 52 6.1 9.3 34.2 39.9 
50 52 1.55 52.5 6.1 8.8 38.3 40.8 
51 55 1.582 64 6.2 9.8 38.3 42.8 
52 60 1.42 47 6.4 9 35.8 36.8 
53 33 1.57 58 6.5 9.5 40 38 
54 41 1.46 48 6.1 9.2 36.9 35 
55 30 1.346 35 6 9 27.6 33 
56 49 1.53 55.5 6.8 9 38.7 40.1 
57 54 1.6 59 6.6 9.8 36 43 
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58 48 1.58 49 5.7 8.8 34.3 35.8 
59 52 1.45 49 6.6 9.1 36.1 37.1 
60 60 1.54 58 6.8 9.3 41 40.3 
61 49 1.42 64 6.6 9.6 42.5 45.2 
62 55 1.51 63.1 6.4 9.7 38.1 42.1 
63 53 1.53 61.4 6.3 9.7 39.9 43.2 
64 49 1.59 52.3 5.7 8.9 28.1 39.2 
65 50 1.592 69 6.9 10.3 38 41 
66 46 1.55 73.2 7.1 10.9 43.2 47.1 
67 51 1.521 48.4 5.9 8.7 33.4 36.2 
68 53 1.692 69 7.3 9.8 38.2 43.4 
69 47 1.581 51 5.8 9.1 29.1 35.7 
70 58 1.542 63 6.1 9.7 36.4 39.9 
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 We calculated body mass index (BMI) and body 
fat mass (BFM) using the data obtained from 
anthropometric measurements and the values are 
tabulated. 
  BMI = Body Weight (Kg) 
Height2 (m2) 
 
    BFM = BFW x 100 
        TBW 
 
Body fat weight (BFW) = Body fat Weight (TBW) – 
Lean Body         Mass (LBM) 
LBM = Factor 1 + ((factor 2 +factor 5) – (factor 3 
+factor 4)) 
Factor 1 = TBW x 0.732) + 8.987 
Factor 2 = Wrist circumference 
    3.140 
Factor 3 = Waist circumference x 0.157 
Factor 4 = Hip circumference x 0.249 
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Factor 5 = Forearm circumference x 0.434 
 
CONVERSION FACTORS 
 
Height (m) → x 39.37 → Height (inch) 
Weight (kg) → x 2.2046 → Weight (lb) 
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CALCULATION OF OBESITY MARKERS (BMI AND BFM) 
TABLE 2 
CODE AGE 
HT 
(m) 
Ht (inch) 
(x 39.37) 
TBW 
(kg) 
Wt (lb) 
(x2.2046) 
WRIST FORE-ARM WAIST HIP 
TBW 
(lb) 
1 35 1.52 59.8424 40 88.184 5.9 8.5 26.5 33.8 64.55069 
2 25 1.472 57.95264 42 92.5932 5.5 8.4 31.8 33.5 67.77822 
3 24 1.575 62.00775 55 121.253 6 9 31 38.3 88.7572 
4 24 1.665 65.55105 61 134.4806 6 8.9 35.2 41 98.4398 
5 24 1.528 60.15736 46.5 102.5139 6.1 9.1 29 35.1 75.04017 
6 30 1.55 61.0235 63.5 139.9921 6.5 9.8 35 41.6 102.4742 
7 38 1.58 62.2046 68.5 151.0151 6.9 10.2 37 41.8 110.5431 
8 24 1.55 61.0235 43 94.7978 5.4 7.9 27 35.1 69.39199 
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9 25 1.6 62.992 66 145.5036 6.1 9.6 40.8 42.3 106.5086 
10 21 1.57 61.8109 43 94.7978 5.5 8.4 26.5 33.5 69.39199 
11 24 1.64 64.5668 49 108.0254 5.6 8.2 27 34.9 79.07459 
12 24 1.66 65.3542 55 121.253 5.9 9 30 39.3 88.7572 
13 25 1.58 62.2046 43 94.7978 5.4 8 28 35 69.39199 
14 28 1.61 63.3857 50 110.23 5.6 8.8 30 38.5 80.68836 
15 23 1.45 57.0865 42 92.5932 5.4 8.4 26 32.9 67.77822 
16 23 1.67 65.7479 54 119.0484 5.2 8.1 29.5 37.9 87.14343 
17 30 1.57 61.8109 76 167.5496 6.3 10.9 44 45.5 122.6463 
18 23 1.656 65.19672 41 90.3886 5.3 7.8 29 34.5 66.16446 
19 30 1.615 63.58255 56 123.4576 6.4 9.6 35.3 42 90.37096 
20 22 1.615 63.58255 50 110.23 6.1 8.5 32.8 36.2 80.68836 
21 47 1.478 58.18886 76 167.5496 7 11.4 45 48.5 122.6463 
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22 39 1.56 61.4172 40 88.184 5.8 8.5 31.6 33 64.55069 
`23 21 1.5 59.055 65 143.299 6.4 10 39.8 43.5 104.8949 
24 20 1.59 62.5983 35 77.161 5.1 7.6 27.2 32.1 56.48185 
25 21 1.568 61.73216 50 110.23 5.8 8.9 32.8 35.5 80.68836 
26 21 1.564 61.57468 39 85.9794 5.6 8.3 29.2 33.8 62.93692 
27 20 1.502 59.13374 42 92.5932 6.4 8.9 30.6 34.1 67.77822 
28 25 1.543 60.74791 52 114.6392 5.9 9 32 39.3 83.91589 
29 23 1.668 65.66916 40 88.184 7.8 7.9 30.2 33.2 64.55069 
30 28 1.472 57.95264 41 90.3886 6 8.9 31.8 34 66.16446 
31 22 1.57 61.8109 46 101.4116 5.8 8.4 35.3 36 74.23329 
32 20 1.536 60.47232 47 103.6162 6 9 32.5 36.8 75.84706 
33 19 1.578 62.12586 43 94.7978 6.1 8.6 30.1 33 69.39199 
34 18 1.617 63.66129 47 103.6162 6.1 9 31.5 33.8 75.84706 
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35 21 1.525 60.03925 45.5 100.3093 5.8 8.9 31.9 34.8 73.42641 
36 26 1.57 61.8109 49 108.0254 5.8 8.5 32 36 79.07459 
37 20 1.563 61.53531 42.5 93.6955 6 8.5 30.7 33 68.58511 
38 21 1.612 63.46444 51 112.4346 6.2 8.8 34.3 35.5 82.30213 
39 29 1.59 62.5983 56.5 124.5599 6 10.1 35.8 38.8 91.17785 
40 42 1.582 62.28334 47 103.6162 5.6 8.8 34 35.3 75.84706 
41 26 1.54 60.6298 75 165.345 7.5 10.6 42.8 42 121.0325 
42 25 1.42 55.9054 44 97.0024 5.7 8.5 34.5 36 71.00576 
43 28 1.603 63.11011 40 88.184 5.2 7.9 32 34.3 64.55069 
44 50 1.48 58.2676 50 110.23 6.2 8.9 37.8 39.8 80.68836 
45 65 1.457 57.36209 45 99.207 6.3 9 36.9 35.5 72.61952 
46 40 1.478 58.18886 45.5 100.3093 6.2 8.8 33 36 73.42641 
47 37 1.507 59.33059 45.5 100.3093 6.8 9.3 35 34.2 73.42641 
Results and Discussion  
  
A Study on Insulin Resistance and Obesity among Women at High Risk for Breast Cancer 
Using Cluster Analysis 
78 
48 27 1.538 60.55106 54.5 120.1507 6.6 9.1 39 38.8 87.95031 
49 35 1.485 58.46445 52 114.6392 6.1 9.3 34.2 39.9 83.91589 
50 52 1.55 61.0235 52.5 115.7415 6.1 8.8 38.3 40.8 84.72278 
51 55 1.582 62.28334 64 141.0944 6.2 9.8 38.3 42.8 103.2811 
52 60 1.42 55.9054 47 103.6162 6.4 9 35.8 36.8 75.84706 
53 33 1.57 61.8109 58 127.8668 6.5 9.5 40 38 93.5985 
54 41 1.46 57.4802 48 105.8208 6.1 9.2 36.9 35 77.46083 
55 30 1.346 52.99202 35 77.161 6 9 27.6 33 56.48185 
56 49 1.53 60.2361 55.5 122.3553 6.8 9 38.7 40.1 89.56408 
57 54 1.6 62.992 59 130.0714 6.6 9.8 36 43 95.21226 
58 48 1.58 62.2046 49 108.0254 5.7 8.8 34.3 35.8 79.07459 
59 52 1.45 57.0865 49 108.0254 6.6 9.1 36.1 37.1 79.07459 
60 60 1.54 60.6298 58 127.8668 6.8 9.3 41 40.3 93.5985 
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61 49 1.42 55.9054 64 141.0944 6.6 9.6 42.5 45.2 103.2811 
62 55 1.51 59.4487 63.1 139.1103 6.4 9.7 38.1 42.1 101.8287 
63 53 1.53 60.2361 61.4 135.3624 6.3 9.7 39.9 43.2 99.08531 
64 49 1.59 62.5983 52.3 115.3006 5.7 8.9 28.1 39.2 84.40002 
65 50 1.592 62.67704 69 152.1174 6.9 10.3 38 41 111.3499 
66 46 1.55 61.0235 73.2 161.3767 7.1 10.9 43.2 47.1 118.1278 
67 51 1.521 59.88177 48.4 106.7026 5.9 8.7 33.4 36.2 78.10633 
68 53 1.692 66.61404 69 152.1174 7.3 9.8 38.2 43.4 111.3499 
69 47 1.581 62.24397 51 112.4346 5.8 9.1 29.1 35.7 82.30213 
70 58 1.542 60.70854 63 138.8898 6.1 9.7 36.4 39.9 101.6673 
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CODE FACTOR 1 FACTOR 2 FACTOR 3 FACTOR 4 FACTOR 5 LBM BFW BFM BMI (m) BMI(lb) 
1 73.53769 1.878981 4.1605 8.4162 3.689 66.52897 21.65503 24.55664 17.31302 17.3112 
2 76.76522 1.751592 4.9926 8.3415 3.6456 68.82831 23.76489 25.66591 19.38357 19.38153 
3 97.7442 1.910828 4.867 9.5367 3.906 89.15732 32.09568 26.47001 22.17183 22.1695 
4 107.4268 1.910828 5.5264 10.209 3.8626 97.46483 37.01577 27.52499 22.00399 22.00167 
5 84.02717 1.942675 4.553 8.7399 3.9494 76.62635 25.88755 25.25272 19.91619 19.91409 
6 111.4612 2.070064 5.495 10.3584 4.2532 101.9311 38.06102 27.18798 26.4308 26.42802 
7 119.5301 2.197452 5.809 10.4082 4.4268 109.9371 41.07799 27.20125 27.43951 27.43663 
8 78.37899 1.719745 4.239 8.7399 3.4286 70.54843 24.24937 25.58009 17.89802 17.89614 
9 115.4956 1.942675 6.4056 10.5327 4.1664 104.6664 40.83719 28.0661 25.78125 25.77854 
10 78.37899 1.751592 4.1605 8.3415 3.6456 71.27418 23.52362 24.81452 17.44493 17.44309 
11 88.06159 1.783439 4.239 8.6901 3.5588 80.47473 27.55067 25.50388 18.21832 18.21641 
12 97.7442 1.878981 4.71 9.7857 3.906 89.03348 32.21952 26.57215 19.95936 19.95726 
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13 78.37899 1.719745 4.396 8.715 3.472 70.45973 24.33807 25.67366 17.2248 17.22299 
14 89.67536 1.783439 4.71 9.5865 3.8192 80.9815 29.2485 26.53407 19.28938 19.28735 
15 76.76522 1.719745 4.082 8.1921 3.6456 69.85647 22.73673 24.55551 19.97622 19.97412 
16 96.13043 1.656051 4.6315 9.4371 3.5154 87.23328 31.81512 26.72453 19.36247 19.36044 
17 131.6333 2.006369 6.908 11.3295 4.7306 120.1328 47.41682 28.30017 30.83289 30.82965 
18 75.15146 1.687898 4.553 8.5905 3.3852 67.08105 23.30755 25.78594 14.95076 14.94918 
19 99.35796 2.038217 5.5421 10.458 4.1664 89.56248 33.89512 27.45487 21.47054 21.46828 
20 89.67536 1.942675 5.1496 9.0138 3.689 81.14364 29.08636 26.38698 19.17013 19.16811 
21 131.6333 2.229299 7.065 12.0765 4.9476 119.6687 47.88089 28.57715 34.79082 34.78716 
22 73.53769 1.847134 4.9612 8.217 3.689 65.89562 22.28838 25.27486 16.43655 16.43483 
23 113.8819 2.038217 6.2486 10.8315 4.34 103.18 40.11902 27.99672 28.88889 28.88585 
24 65.46885 1.624204 4.2704 7.9929 3.2984 58.12816 19.03284 24.6664 13.84439 13.84293 
25 89.67536 1.847134 5.1496 8.8395 3.8626 81.39599 28.83401 26.15804 20.33658 20.33444 
26 71.92392 1.783439 4.5844 8.4162 3.6022 64.30896 21.67044 25.20422 15.94377 15.9421 
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27 76.76522 2.038217 4.8042 8.4909 3.8626 69.37094 23.22226 25.07988 18.61699 18.61503 
28 92.90289 1.878981 5.024 9.7857 3.906 83.87818 30.76102 26.8329 21.84095 21.83865 
29 73.53769 2.484076 4.7414 8.2668 3.4286 66.44216 21.74184 24.65508 14.37699 14.37547 
30 75.15146 1.910828 4.9926 8.466 3.8626 67.46628 22.92232 25.35974 18.92205 18.92006 
31 83.22029 1.847134 5.5421 8.964 3.6456 74.20692 27.20468 26.826 18.66201 18.66005 
32 84.83406 1.910828 5.1025 9.1632 3.906 76.38519 27.23101 26.28065 19.9212 19.9191 
33 78.37899 1.942675 4.7257 8.217 3.7324 71.11136 23.68644 24.98627 17.26849 17.26668 
34 84.83406 1.942675 4.9455 8.4162 3.906 77.32103 26.29517 25.37747 17.97537 17.97348 
35 82.41341 1.847134 5.0083 8.6652 3.8626 74.44964 25.85966 25.77992 19.56463 19.56257 
36 88.06159 1.847134 5.024 8.964 3.689 79.60973 28.41567 26.30462 19.8791 19.87701 
37 77.57211 1.910828 4.8199 8.217 3.689 70.13503 23.56047 25.14578 17.39686 17.39503 
38 91.28913 1.974522 5.3851 8.8395 3.8192 82.85825 29.57635 26.30538 19.62638 19.62431 
39 100.1648 1.910828 5.6206 9.6612 4.3834 91.17727 33.38263 26.80046 22.3488 22.34645 
40 84.83406 1.783439 5.338 8.7897 3.8192 76.309 27.3072 26.35418 18.77954 18.77756 
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41 130.0195 2.388535 6.7196 10.458 4.6004 119.8309 45.51412 27.52676 31.62422 31.62089 
42 79.99276 1.815287 5.4165 8.964 3.689 71.11654 25.88586 26.68579 21.82107 21.81877 
43 73.53769 1.656051 5.024 8.5407 3.4286 65.05764 23.12636 26.22512 15.56657 15.56493 
44 89.67536 1.974522 5.9346 9.9102 3.8626 79.66768 30.56232 27.72595 22.82688 22.82448 
45 81.60652 2.006369 5.7933 8.8395 3.906 72.88609 26.32091 26.5313 21.19793 21.1957 
46 82.41341 1.974522 5.181 8.964 3.8192 74.06213 26.24717 26.16624 20.82872 20.82653 
47 82.41341 2.165605 5.495 8.5158 4.0362 74.60441 25.70489 25.62563 20.03479 20.03269 
48 96.93731 2.101911 6.123 9.6612 3.9494 87.20442 32.94628 27.42079 23.04007 23.03765 
49 92.90289 1.942675 5.3694 9.9351 4.0362 83.57727 31.06193 27.09538 23.58036 23.57788 
50 93.70978 1.942675 6.0131 10.1592 3.8192 83.29935 32.44215 28.02983 21.85224 21.84994 
51 112.2681 1.974522 6.0131 10.6572 4.2532 101.8255 39.26888 27.83163 25.57214 25.56945 
52 84.83406 2.038217 5.6206 9.1632 3.906 75.99447 27.62173 26.65773 23.30887 23.30641 
53 102.5855 2.070064 6.28 9.462 4.123 93.03656 34.83024 27.23947 23.53037 23.52789 
54 86.44783 1.942675 5.7933 8.715 3.9928 77.875 27.9458 26.40861 22.5183 22.51593 
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55 65.46885 1.910828 4.3332 8.217 3.906 58.73548 18.42552 23.87932 19.3187 19.31667 
56 98.55108 2.165605 6.0759 9.9849 3.906 88.56188 33.79342 27.61909 23.70883 23.70634 
57 104.1993 2.101911 5.652 10.707 4.2532 94.19538 35.87602 27.58179 23.04688 23.04445 
58 88.06159 1.815287 5.3851 8.9142 3.8192 79.39678 28.62862 26.50175 19.62826 19.6262 
59 88.06159 2.101911 5.6677 9.2379 3.9494 79.2073 28.8181 26.67715 23.30559 23.30314 
60 102.5855 2.165605 6.437 10.0347 4.0362 92.3156 35.5512 27.80331 24.45606 24.45349 
61 112.2681 2.101911 6.6725 11.2548 4.1664 100.6091 40.48529 28.69376 31.73973 31.73639 
62 110.8157 2.038217 5.9817 10.4829 4.2098 100.5991 38.51113 27.68389 27.67422 27.67131 
63 108.0723 2.006369 6.2643 10.7568 4.2098 97.26738 38.09506 28.14301 26.22923 26.22647 
64 93.38702 1.815287 4.4117 9.7608 3.8626 84.89241 30.40817 26.37295 20.68747 20.6853 
65 120.3369 2.197452 5.966 10.209 4.4702 110.8296 41.28781 27.14207 27.22469 27.22183 
66 127.1148 2.261146 6.7824 11.7279 4.7306 115.5962 45.78051 28.36872 30.46826 30.46506 
67 87.09333 1.878981 5.2438 9.0138 3.7758 78.49051 28.21213 26.43995 20.92122 20.91902 
68 120.3369 2.324841 5.9974 10.8066 4.2532 110.111 42.00642 27.61448 24.10174 24.0992 
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69 91.28913 1.847134 4.5687 8.8893 3.9494 83.62766 28.80694 25.62106 20.40358 20.40144 
70 110.6543 1.942675 5.7148 9.9351 4.2098 101.1569 37.73289 27.1675 26.49548 26.49269 
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CLUSTER ANALYSIS 
We partitioned the complete dataset into 2 based 
on the participants’ age (Graph: 2).  We had 24 
postmenopausal individuals with an age cut-off of >45 in 
cluster1 and the remaining 46 premenopausal individuals 
in cluster2 (Table: 3). 
  
I.  CLUSTERING BASED ON AGE  
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TABLE 3 
CLUSTER FREQUENCY 
1 24 (Post menopausal) 
2 46 
 
CASE ID CLUSTER CASE ID CLUSTER 
1 2 36 2 
2 2 37 2 
3 2 38 2 
4 2 39 2 
5 2 40 1 
6 2 41 2 
7 2 42 2 
8 2 43 2 
9 2 44 1 
10 2 45 1 
11 2 46 1 
12 2 47 2 
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13 2 48 2 
14 2 49 2 
15 2 50 1 
16 2 51 1 
17 2 52 1 
18 2 53 2 
19 2 54 1 
20 2 55 2 
21 1 56 1 
22 2 57 1 
23 2 58 1 
24 2 59 1 
25 2 60 1 
26 2 61 1 
27 2 62 1 
28 2 63 1 
29 2 64 1 
30 2 65 1 
31 2 66 1 
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32 2 67 1 
33 2 68 1 
34 2 69 1 
35 2 70 1 
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CLUSTERING BASED ON BFM AND BMI 
 
On clustering the total population using BFM and BMI 
values eight individuals were identified to be 
overweight/obese.   
 
GRAPH 3 
TABLE 5  
CLUSTER FREQUENCY CASE ID 
1 28  
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2 8 (obese) 7,17, 21, 23, 41, 61, 62,66 
3 34  
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S. 
N
O 
VARIABLES 
TOTAL 
STD 
WITHIN 
STD R
2 RSQ/(1-RSQ) 
1 BFM 1.11900 0.70062 0.619349 1.627076 
2 BMI (lb) 4.36004 2.00031 0.795620 3.892849 
3 OVER-ALL 3.18293 1.49868 0.784727 3.645260 
 
CLUSTER ANALYSIS (PRE-MENOPAUSAL WOMEN) 
 
CASE ID CLUSTER CASE ID CLUSTER 
1 1 36 3 
2 1 37 1 
3 3 38 1 
4 3 39 3 
5 1 40 1 
6 3 41 2 
7 2 42 3 
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8 1 43 1 
9 3 44 3 
10 1 45 3 
11 1 46 3 
12 3 47 3 
13 1 48 3 
14 1 49 3 
15 1 50 3 
16 1 51 3 
17 2 52 3 
18 1 53 3 
19 3 54 3 
20 1 55 1 
21 2 56 3 
22 1 57 3 
23 2 58 1 
24 1 59 3 
25 3 60 3 
26 1 61 2 
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27 1 62 2 
28 3 63 3 
29 1 64 3 
30 1 65 3 
31 1 66 2 
32 3 67 3 
33 1 68 3 
34 1 69 3 
35 1 70 3 
 
 
 
 
 
 
 
CLUSTERING BASED ON FAT DISTRIBUTION [FWWH 
MEASURES]  
Results and Discussion 
 
A Study on Insulin Resistance and Obesity Among Women 
at High Risk for Breast Cancer using Cluster Analysis 
91 
 
 
 We further attempted to cluster the pre-menopausal 
women to identify the variables that has major role in 
body fat distribution.  All four anthropometric 
measurements namely wrist circumference, forearm 
circumference, waist circumference and hip 
circumference were taken into account to estimate body 
fat distribution.  We found that wrist circumference had 
less influence in body fat distribution while waist 
circumference and forearm circumference values of the 
subjects contributed more in defining obesity.  Using the 
measures of body fat distribution six individuals were found 
to be overweight/obese. 
 
TABLE 7 
CLUSTER FREQUENCY 
1 22 
2 18 
3 6 
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S.  
NO 
VARIABL
ES 
TOTAL 
STD 
WITHIN 
STD R
2 RSQ/(1-RSQ) 
1 Wrist 0.54630    0.48275    
0.25381
8     
0.34015
6 
2 Forearm 0.73141    0.48275    
0.61827
2   
1.61966
4 
3 Waist 4.38169   2.19117    
0.76104
1        
3.18482
1 
4 Hip 3.39843    1.87467    
0.70923
0        
2.43914
6 
5 Over-all 2.80989    1.48007    
0.73488
3     
2.77191
6 
 
 
CASE ID CLUSTER CASE ID CLUSTER 
1 1 25 2 
2 1 26 1 
3 2 27 1 
4 1 28 2 
5 1 29 1 
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6 2 30 1 
7 3 31 2 
8 1 32 2 
9 3 33 1 
10 1 34 1 
11 1 35 1 
12 2 36 2 
13 1 37 1 
14 2 38 2 
15 1 39 2 
16 1 41 3 
17 3 42 2 
18 1 43 1 
19 2 47 2 
20 2 48 2 
22 1 49 2 
23 3 53 3 
24 1 55 1 
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CLUSTERING BASED ON TBW AND HEIGHT 
 
 On clustering the pre-menopausal women using two 
variables namely total body weight (TBW) and height we 
found that TBW showed good correlation co-efficient of 
0.864823.  Therefore, based on this cluster six subjects were 
identified as overweight/obese. 
TABLE 8 
CLUSTER FREQUENCY 
1 22 
2 6 
3 18 
 
S. 
NO VARIABLES 
TOTAL 
STD 
WITHIN 
STD R
2 RSQ/(1-RSQ) 
1 TBW (lb) 21.69613 8.16029 0.864823 6.397722 
2 HEIGHT 2.59971 2.42915 0.165713 0.198628 
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(inch) 
3 Over-all 15.45122 6.02042 0.854928 5.893117 
 
CASE ID CLUSTER CASE ID CLUSTER 
1 1 25 3 
2 1 26 1 
3 3 27 1 
4 3 28 3 
5 1 29 1 
6 2 30 1 
7 2 31 1 
8 1 32 3 
9 2 33 1 
10 1 34 3 
11 3 35 1 
12 3 36 3 
13 1 37 1 
14 3 38 3 
15 1 39 3 
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16 3 41 2 
17 2 42 1 
18 1 43 1 
19 3 47 1 
20 3 48 3 
22 1 49 3 
23 2 53 3 
24 1 55 1 
 
 
CLUSTERING BASED ON ANTHROPOMETRIC MEASURES 
 
On performing cluster analysis using all the variables 
namely TBW, height, wrist circumference, forearm 
circumference, waist circumference and hip 
circumference in the pre-menopausal population we 
found that TBW, forearm circumference and hip 
circumference were useful in defining obesity and six 
women were identified as overweight/obese.  
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TABLE 9 
CLUSTER FREQUENCY 
1 22 
2 6 
3 18 
 
S. 
NO VARIABLES 
TOTAL 
STD 
WITHIN 
STD R
2 RSQ/(1-RSQ) 
1 TBW (lb) 21.69613 8.16029 0.864823 6.397722 
2 
HEIGHT 
(inch) 
2.59971 2.42915 0.165713 0.198628 
3 WRIST 0.54630 0.49698 0.209171 0.264496 
4 FOREARM 0.73141 0.47063 0.604362 1.527564 
5 WAIST 4.38169 3.04949 0.537166 1.160603 
6 HIP 3.39843 1.63513 0.778790 3.520598 
7 OVER-ALL 9.21107 3.76237 0.840574 5.272508 
 
CASE ID CLUSTER CASE ID CLUSTER 
1 1 25 3 
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2 1 26 1 
3 3 27 1 
4 3 28 3 
5 1 29 1 
6 2 30 1 
7 2 31 1 
8 1 32 3 
9 2 33 1 
10 1 34 3 
11 3 35 1 
12 3 36 3 
13 1 37 1 
14 3 38 3 
15 1 39 3 
16 3 41 2 
17 2 42 1 
18 1 43 1 
19 3 47 1 
20 3 48 3 
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22 1 49 3 
23 2 53 3 
24 1 55 1 
 
SUMMARY OF CLUSTER ANALYSIS IN PRE-MENOPAUSAL 
WOMEN 
 
TABLE 10 
CASE ID OF  
OBESE SUBJECTS 
S. 
NO 
VARIABLES 
CLUSTER 
NUMBER OF 
CASES 
1 Circumferences 
of   forearm, 
wrist, waist and 
hip  
7, 9, 17, 23, 41, 53 6 
2 TBW, height, 
circumferences 
of forearm, wrist, 
waist and hip. 
6, 7, 9, 17, 23, 41 6 
 
3 TBW and height 6, 7, 9, 17, 23, 41 6 
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 It is evident that the pre-menopausal women with ID 
no 7, 9, 17, 23 and 41 are overweight/obese from the 
summary of cluster analysis. 
 
CLUSTER ANALYSIS IN POST-MENOPAUSAL INDIVIDUALS 
 
Clustering Based On All Anthropometric Measures  
On performing cluster analysis using all the variables 
namely TBW, height, wrist circumference, forearm 
circumference, waist circumference and hip 
circumference in the post-menopausal population we 
found that TBW, forearm circumference and hip 
circumference were useful in defining obesity and two 
women were identified as overweight/obese.  Since we 
observed that the same parameters contributed in 
defining obesity in pre-menopausal population, we 
conclude that the above three variables are useful to 
stratify individuals using anthropometric measures based 
on cluster analysis. 
 
TABLE 11 
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CLUSTER FREQUENCY 
1 2 
2 12 
3 10 
 
 
 
 
S. NO VARIABLES 
TOTAL 
STD 
WITHIN 
STD R
2 RSQ/(1-RSQ) 
1 TBW (lb) 20.52239 7.46815 0.879090 7.270626 
2 HEIGHT (inch) 2.58763 2.56981 0.099493 0.110486 
3 WRIST 0.46421 0.32914 0.540984 1.178571 
4 FOREARM 0.69092 0.26081 0.869895 6.686093 
5 WAIST 3.94593 2.68675 0.576700 1.362391 
6 HIP 3.88832 1.81405 0.801268 4.031907 
7 OVER-ALL 8.74878 3.48958 0.854741 5.884259 
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CASE ID CLUSTER CASE ID CLUSTER CASE ID CLUSTER CASE ID CLUSTER 
21 1 51 3 59 2 65 3 
40 2 52 2 60 3 66 1 
44 2 54 2 61 3 67 2 
45 2 56 3 62 3 68 3 
46 2 57 3 63 3 69 2 
50 2 58 3 64 2 70 3 
 
 
 
 
 
 
 
CLUSTERING BASED ON FAT DISTRIBUTION (FWWH 
MEASURES) 
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When we attempted to cluster the post-menopausal 
population based on fat distribution measures we were 
able to identify the variable that has major role in body fat 
distribution.  All four anthropometric measurements 
namely wrist circumference, forearm circumference, waist 
circumference and hip circumference were taken into 
account to estimate body fat distribution.  We found that 
only waist circumference and hip circumference values of 
the subjects contributed much in defining obesity.  Using 
the measures of body fat distribution three individuals 
were found to be overweight/obese. 
 
TABLE 12 
CLUSTER FREQUENCY 
1 3 (Obese) 
2 7 
3 14 (overweight) 
 
S. 
NO VARIABLES 
TOTAL 
STD 
WITHIN 
STD R
2 RSQ/(1-RSQ) 
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1 WRIST 0.46421    0.31146       0.588975  1.432942 
2 FOREARM     
0.69092     
0.47158       0.574643  1.350969 
3 WAIST 3.94593    2.05934       0.751315  3.021144 
4 HIP 3.88832    2.16595       0.716689  2.529690 
5 OVER-ALL    2.80099  1.52082       0.730831  2.715136 
 
CASE ID CLUSTER CASE ID CLUSTER CASE ID CLUSTER CASE ID CLUSTER 
21 1 51 3 59 3 65 3 
40 2 52 3 60 3 66 1 
44 3 54 2 61 1 67 2 
45 3 56 3 62 3 68 3 
46 2 57 3 63 3 69 2 
50 3 58 2 64 2 70 3 
 
CLUSTERING BASED ON TBW AND HEIGHT 
 
On clustering the post-menopausal women using 
two variables namely total body weight (TBW) and height 
we found that TBW showed good correlation co-efficient 
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of 0.914734.  Therefore, based on this cluster four subjects 
were identified as overweight/obese. 
 
TABLE 13 
CLUSTER FREQUENCY 
1 4 (Obese) 
2 12 
3 8 (overweight) 
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S. 
NO VARIABLES 
TOTAL 
STD 
WITHIN 
STD R
2 RSQ/(1-RSQ) 
1 TBW (lb) 20.52239    6.27150       0.914734  10.727945 
2 HEIGHT 
(inch) 
2.58763     2.52542      0.130332  0.149864 
3 OVER-ALL  14.62642  4.78066      0.902458  9.252004 
 
CASE ID CLUSTER CASE ID CLUSTER CASE ID CLUSTER CASE ID CLUSTER 
21 1 51 3 59 2 65 1 
40 2 52 2 60 3 66 1 
44 2 54 2 61 3 67 2 
45 2 56 3 62 3 68 1 
46 2 57 3 63 3 69 2 
50 2 58 2 64 2 70 3 
 
CLUSTERING BASED ON WAIST AND HIP CIRCUMFERENCE 
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Since we found that both waist circumference and 
hip circumference contributed in body fat distribution we 
attempted to stratify individuals based on these two 
variables and identified that three subjects fall under 
overweight/obese category.  
 
 
 
 
 
TABLE 14 
CLUSTER FREQUENCY 
1 3 
2 7 
3 14 
 
S. 
NO VARIABLES 
TOTAL 
STD 
WITHIN 
STD R
2 RSQ/(1-RSQ) 
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1 WAIST 3.94593      2.05934       0.751315   3.021144 
2 HIP 3.88832      2.16595       0.716689    2.529690 
3 OVER-ALL 3.91723      2.11332       0.734256    2.763025 
 
CLUSTERING BASED ON WAIST CIRCUMFERENCE  
 
 Cluster analysis of the post-menopausal population 
based on waist circumference clearly stratified the 
subjects into three groups and we found that five 
individuals were obese. 
 
TABLE 15 
CLUSTER FREQUENCY 
1 5 (obese) 
2 2 (lean) 
3 17 (normal) 
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S. 
NO VARIABLES 
TOTAL 
STD 
WITHIN 
STD R
2 RSQ/(1-RSQ) 
1 WAIST 3.94593  1.83838       0.801818  4.045860 
2 OVER-ALL 3.94593  1.83838       0.801818  4.045860 
 
CASE ID CLUSTER CASE ID CLUSTER CASE ID CLUSTER CASE ID CLUSTER 
21 1 51 3 59 3 65 3 
40 3 52 3 60 1 66 1 
44 3 54 3 61 1 67 3 
45 3 56 3 62 3 68 3 
46 3 57 3 63 1 69 2 
50 3 58 3 64 2 70 3 
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SUMMARY OF CLUSTER ANALYSIS IN POST-MENOPAUSAL 
WOMEN  
 
TABLE 16 
CASE ID OF OBESE 
SUBJECTS 
S.NO VARIABLES 
CLUSTER 
NUMBER OF 
CASES 
1 TBW, height, 
circumferences 
of wrist, forearm, 
21, 66 2 
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waist and hip. 
2 Circumferences 
of forearm, wrist, 
waist and hip 
21, 61, 66 3 
3 TBW and height 21, 61, 66, 68 4 
4 Circumferences 
of, waist and hip 
21, 61, 66 3 
5 Waist 
circumference 
21, 60, 61, 63, 66 5 
 
It is evident that the post-menopausal women with ID 
no 21, 61, and 66 are overweight/obese from the 
summary of cluster analysis. 
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HORMONAL PARAMETERS ALTERED IN OBESE BREAST 
CANCER PATIENTS 
  
We attempted to identify the hormonal parameters 
that are significantly altered in obese breast cancer 
patients from the reported data (McTiernan et al. 2003) in 
order to exploit them as screening markers along with 
body mass index (BMI) and body fat mass (BFM).   
 
We found the levels of estradiol (E2), (free estradiol 
FE2), dehydroepiandrosterone (DHEAS), estrone (E1), 
testosterone (T) and free testosterone (FT) were 
significantly elevated except with sex hormone-binding 
globulin (SHBG). 
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REPORTED DATA OF SEX HORMONES IN OBESE BREAST CANCER PATIENTS (McTiernan et al. 2003) 
Table: 17  
HORMONAL PARAMETERS THAT ARE SIGNIFICANTLY ALTERED IN OBESE BREAST CANCER PATIENTS 
 
S.NO CATEGORY TYPE E2 F E2 DHEAS E1 SHBG T FT 
I a. BMI LIGHT  4.7 0.1 50.5 19.7 73.9 94.5 2.1 
b BMI NORMAL 8.3 0.18 53.2 22.3 66.2 118.1 2.9 
c BMI M OWT  8 0.2 55.6 21.2 52.1 127.4 4 
d BMI S OWT  10.6 0.28 60 22.7 43.4 126 4.6 
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e BMI OBESE 10.7 0.28 59.3 26.5 38.1 176.5 7.6 
II.a BFM LIGHT  6.6 0.14 48.4 19.9 73.6 99.9 2.2 
b BFM NORMAL 6.4 0.13 55.1 21.2 62.5 112.5 2.8 
c BFM OVER WT 5.8 0.14 55 20.7 49.7 132.1 4.1 
d BFM OBESE 12.2 0.35 57.3 26.1 38.4 168.6 7.2 
 
 
TABLE 18 
T/ E/ E1/ EST* E2* FE2* 
S.NO METH TYPE 
SHBG 
T/FT SHBG/T SHBG/F E2 SHBG/E2 FE2 E2 
E2/ F 
E2 E2/T E2 F E2 10 
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I a. BMI LIGHT 1.28 45 0.782 73.9 15.72 47 92.59 47 0.0497 92.59 0.47 1 
b BMI NORMAL 1.78 40.7 0.5605 36.78 7.98 46.11 185.09 46.11 0.0703 185.1 1.49 1.8 
c BMI M OWT 2.45 31.9 0.4089 26.05 6.51 40 169.6 40 0.0628 169.6 1.6 2 
d BMI S OWT 2.9 27.4 0.3444 15.5 4.094 37.86 240.62 37.86 0.0841 240.6 2.968 2.8 
e BMI OBESE 4.63 23.2 0.2159 13.61 3.56 38.21 283.55 38.21 0.0606 283.6 2.996 2.8 
II.a BFM LIGHT 1.36 45.4 0.7367 52.57 11.15 47.14 3.02 47.14 0.0661 131.3 0.924 1.4 
b BFM NORMAL 1.8 40.2 0.5556 48.08 9.77 49.23 3.31 49.23 0.0569 135.7 0.83 1.3 
c BFM OVERWT 2.66 32.2 0.3762 35.5 8.57 41.43 3.57 41.43 0.0439 120.1 0.812 1.4 
d BFM OBESE 4.39 23.4 0.2278 10.97 3.15 34.86 2.14 34.86 0.0724 318.4 4.27 3.5 
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CALCULATION OF PERCENTAGE SHIFT USING REPORTED DATA 
TABLE 19 
OBESE BREAST CANCER PATIENTS 
BASED ON BMI BASED ON BFM 
% SHIFT FROM  
OVERWEIGHT S.NO PARAMETERS 
LIGHT N M.OVT S.OVT OBESE LIGHT N OVERWT OBESE BMI  BFM 
1 T 94.5 118.1 127.4 126 176.5 99.9 112.5 132.1 168.6 28.61 21.65 
2 FT 2.1 2.9 4 4.6 7.6 2.2 2.8 4.1 7.2 39.47 43.06 
3 T/SHBG 1.28 1.78 2.45 2.9 4.63 1.36 1.8 2.66 4.39 37.36 39.41 
4 E1 x E2 92.59 185.09 169.6 240.62 283.55 131.34 135.68 120.06 318.42 15.14 62.29 
5 E2 x FE2 0.47 1.49 1.6 2.968 2.996 0.924 0.83 0.812 4.27 0.935 80.98 
6 SHBG/E2 15.72 7.98 6.51 4.094 3.56 11.15 9.77 8.57 3.15 13.04 63.24 
 Therefore the anthropometric measures of postmenopausal women are important for the 
breast cancer risk prediction. 
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GRAPHS USING REPORTED HORMONAL PARAMETERS 
GRAPH: 4 
TESTOSTERONE AND FREE TESTOSTERONE (BMI) 
 
 
GRAPH 5 
RATIO OF T/SHBG (BMI) 
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PRODUCTS OF TOTAL AND BIOAVAILABLE ESTROGENS  
GRAPH 6 
 
 
RATIO OF SHBG AND ESTRADIOL (BFM) 
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GRAPH 7 
 
 
With the percentage shift values (Table: 19) and from 
the graphs (4-7) it is evident that obese postmenopausal 
individuals with elevated estradiol (E2), (free estradiol FE2), 
and estrone (E1), should be evaluated based on their BFM 
values for assessing their breast cancer risk.  The ratio of 
sex hormone-binding globulin to estradiol value is found to 
be declining among obese individuals. 
 
SHBG AS A GENERALIZED BODY WEIGHT MARKER 
GRAPH 8 
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The sex hormone-binding globulin values are 
showing a strong linear negative correlation with body 
weight across all categories of breast cancer patients.  As 
this observation is also seen in normal individuals, SHBG 
can be considered as a general marker for obesity. 
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DATA OF 29 HEALTHY FEMALE INDIVIDUALS 
TABLE 20 
ANTH CASE ID CASE ID STATUS AGE HT IN INCH TBW IN LB WRIST FOREARM WAIST HIP 
9G 51  25 62.992 145.5036 6.1 9.6 40.8 42.3 
13G 81  25 62.2046 94.7978 5.4 8 28 35 
77GN 131  24 62.5983 141.0944 6 9 34.2 38 
72GN 2  24 67.3227 169.7542 6.4 11 38 42 
11G 71 FH 24 64.5668 108.0254 5.6 8.2 27 34.9 
3G 181 FH 24 62.00775 121.253 6 9 31 38.3 
12GG 62  24 104.7242 123.4576 5.9 9 30 39.3 
79GNN 122 FH 24 62.992 116.8438 5.5 9.2 32 37.4 
79GN 121 FH 24 62.992 116.8438 5.5 9.2 32 37.4 
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2G 171 FH 25 57.95264 92.5932 5.5 8.4 31.8 33.5 
2GG 172 FH 25 57.95264 92.5932 5.5 8.4 31.8 33.5 
11GG 72 FH 24 103.9368 110.23 5.6 8.2 27 34.9 
82GN 21 FH 27 63.3857 154.322 7 10 35 40 
71GN 14  24 61.4172 108.0254 5.8 9 28 34 
19G 19  30 67.3227 169.7542 6.4 11 38 42 
74GN 1  24 61.0235 101.4116 5.9 8.2 28.4 35 
9GG 52  25 62.992 145.5036 6.1 9.6 40.8 42.3 
5G 16  24 60.15736 102.5139 6.1 9.1 29 35.1 
4G 4  24 65.55105 134.4806 6 8.9 35.2 41 
76GN 10  24 61.8109 121.253 6 9.5 29 37.4 
80GN 9  25 64.9605 165.345 6 9.5 35 43 
75GN 15  24 61.0235 154.322 6 10.3 32 38 
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73GN 3  24 65.15735 125.6622 6 9 31 36 
13GG 82  25 62.2046 94.7978 5.4 8 28 35 
77GNN 132  24 62.5983 141.0944 6 9 34.2 38 
81GN 20  25 63.3857 116.8438 6 9 34 37 
78GN 11  24 64.36995 99.207 6 8 26 35 
3GG 182  24 62.00775 121.253 6 9 31 38.3 
12G 61  24 65.3542 121.253 5.9 9 30 39.3 
CALCULATION OF BMI AND BFM OF 29 PREMENOPAUSAL WOMEN 
TABLE 21 
ANTH CASE ID CASE ID STATUS AGE LBM BFW BFM BMI(lb) 
9G 51  25 104.6664 40.83719 28.0661 25.77854 
13G 81  25 70.45973 24.33807 25.67366 17.22299 
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77GN 131  24 103.2535 37.84087 26.81954 25.31279 
72GN 2  24 123.6353 46.11891 27.16805 26.33012 
11G 71 FH 24 80.47473 27.55067 25.50388 18.21641 
3G 181 FH 24 89.15732 32.09568 26.47001 22.1695 
12GG 62  24 90.64724 32.81036 26.57621 7.91369 
79GNN 122 FH 24 85.92445 30.91935 26.46212 20.70095 
79GN 121 FH 24 85.92445 30.91935 26.46212 20.70095 
2G 171 FH 25 68.82831 23.76489 25.66591 19.38153 
2GG 172 FH 25 68.82831 23.76489 25.66591 19.38153 
11GG 72 FH 24 82.0885 28.1415 25.5298 7.173258 
82GN 21 FH 27 113.065 41.257 26.73436 27.00229 
71GN 14  24 80.95273 27.07267 25.0614 20.13266 
19G 19  30 123.6353 46.11891 27.16805 26.33012 
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74GN 1  24 75.48427 25.92733 25.56643 19.14471 
9GG 52  25 104.6664 40.83719 28.0661 25.77854 
5G 16  24 76.62635 25.88755 25.25272 19.91409 
4G 4  24 97.46483 37.01577 27.52499 22.00167 
76GN 10  24 89.91242 31.34058 25.84726 22.31093 
80GN 9  25 119.8514 45.49363 27.51437 27.54531 
75GN 15  24 113.8457 40.47627 26.22845 29.13325 
73GN 3  24 92.95756 32.70464 26.02584 20.80814 
13GG 82  25 70.45973 24.33807 25.67366 17.22299 
77GNN 132  24 103.2535 37.84087 26.81954 25.31279 
81GN 20  25 85.78249 31.06131 26.58362 20.44459 
78GN 11  24 74.19235 25.01465 25.2146 16.83183 
3GG 182  24 89.15732 32.09568 26.47001 22.1695 
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12G 61  24 89.03348 32.21952 26.57215 19.95726 
ORAL GLUCOSE TOLERANCE TEST (OGTT) AND INSULIN ASSAY VALUES 
TABLE 22 
`1` CASE ID STATUS AGE 0MIN 30MIN 60MIN 90MIN 120MIN INS 0MIN 
INS 
30MIN 
INS 
120MIN 
9G 51  25 94 131 84 75 83 3.7 66.7 2.2 
13G 81  25 91 96 68 70 89  53.4  
77GN 131  24 81 115 139 126 79  52.6  
72GN 2  24 59 135 111 86 77 6.4 53.6 12.5 
11G 71 FH 24 104 118 159 116 103  33.2  
3G 181 FH 24 103 156 147 110 98  29  
12GG 62  24 90 133 112 70 93 3.1 17.2 2.8 
79GNN 122 FH 24 78 159 178 148 125    
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79GN 121 FH 24 75 161 176 148 129    
2G 171 FH 25 81 166 176 119 70    
2GG 172 FH 25 83 151 175 119 75    
11GG 72 FH 24 105 133 154 138 89    
82GN 21 FH 27 98 110 140 129 88    
71GN 14  24 65 133 134 109 74    
19G 19  30 98 147 132 114 100    
74GN 1  24 77 133 124 93 82    
9GG 52  25 94 137 124 104 95    
5G 16  24 109 137 123 109 98    
4G 4  24 87 147 122 111 84    
76GN 10  24 91 131 119 96 105    
80GN 9  25 81 141 118 96 85    
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75GN 15  24 88 131 117 102 89    
73GN 3  24 88 131 115 91 84    
13GG 82  25 94 156 115 100 93    
77GNN 132  24 87 128 115 97 107    
81GN 20  25 80 137 114 105 96    
78GN 11  24 97 136 113 100 68    
3GG 182  24 101 133 111 111 98    
12G 61  24 93 104 98 60 94    
CALCULATION OF INSULIN SENSITIVITY & INSULIN SECRETION INDICES: 
TABLE 23 
CASE ID ANTH CASE ID 
HOMA2 
%B 
HOMA2 
%S 
HOMA2 
IR 
HOMA2 
%B30 
HOMA2 
%S30 
HOMA2 
IR30 log IR 
1/LOG 
IR log IR30 
1/LOG 
IR30 
51 9G 53.3 204 0.5 - - - -0.301 -3.322   
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81 13G    316 15.4 6.5   0.8129 1.23014 
131 77GN    227 15 6.7   0.8261 1.21054 
2 72GN 197.6 136 0.7 176 14.2 7 -0.155 -6.456 0.8451 1.1833 
71 11G    156 22.8 4.4   0.6435 1.55412 
181 3G    86.6 24.4 4.1   0.6128 1.6319 
62 12GG 51.8 246 0.4 78.2 41.6 2.4 -0.398 -2.513 0.3802 2.63012 
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GRAPHS DEMONSTRATING THE RELATIONSHIP BETWEEN 
INSULIN RESISTANCE WITH OBESITY 
 
GRAPH 9 
Correlation of Insulin Resistance with Obesity
y = 0.8932x + 16.905
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Correlation of Insulin Sensitivity with Obesity
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GRAPH 11 
Correlation of Insulin Secretion with Obesity
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Correlation of Obesity with Insulin Resistance
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GRAPH 13 
Correlation of Obesity with Insulin Resistance
y = -2.186x + 24.974
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GRAPH 14 
B Cell Function Vs 1st Phase Insulin Secretion
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Insulin Response - hyperbolic Curve
y = 4464.3x-1.1134
R2 = 0.7188
0
50
100
150
200
250
300
350
0 5 10 15 20 25 30 35 40 45 50
Insulin Sensitivity (HOMA2 %S30)
B
 C
el
l R
es
po
ns
iv
ity
 (H
O
M
A
2 
%
B
30
)
 
 
 We have correlated the obesity marker BMI with the 
indices of oral glucose tolerance test (OGTT) surrogate 
measures of insulin response to demonstrate only a weak, 
positive correlation between insulin resistance and 
obesity.  This could be due to the relatively small number 
of subjects included in the study.  However, when BMI 
values were plotted against insulin resistance indices 
(HOMA 2 IR and log HOMA 2 IR) a weak, positive 
correlation was observed (graph 9 and 12) while it was 
plotted against insulin sensitivity indices HOMA 2% S, a 
weak, linear, negative correlation was observed).  This is 
consistent with the principle of insulin resistance and insulin 
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sensitivity as they are inversely related to each other.  
Similarly, when BMI was plotted against log 1/HOMA 2 IR 
as well as HOMA 2% B we observed a weak, linear 
negative correlation (graph 10, 11 and 13).  When the 
values of index of β-cell responsivity, HOMA 2% B is plotted 
against the index of first phase insulin secretion, insulin 30 
minutes a good strong, linear, positive correlation is 
observed (graph:14).   This is expected as both the 
indices represent insulin release.  A hyperbolic-like 
relationship was observed between insulin sensitivity and 
insulin secretion when HOMA 2% B values were plotted 
against HOMA 2% S values (graph: 15).  Generally such a 
relationship (between insulin sensitivity and insulin 
secretion) is used to understand the nature of type-2 
diabetes.  Glucose tolerance is bad if an individual is 
located below the hyperbolic line, drawn from OGTT 
values of NGT individuals.  Glucose tolerance is good if an 
individual is located on or above that line. 
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QUESTIONNAIRE DEVELOPED USING EXISTING MODELS 
 
Gail Model  - G Shattuck – Eidens -
 SE 
Claus Model  - CL Couch  - Co 
BRCAPRO  - BR Frank   - FR 
Cuzick- Tyrer - CT Rosner & Colditz - RC 
BOADICEA - BO Gilpin   - GI
  
FORD  - F Evans   - EV 
 
Results and Discussion 
 
A Study on Insulin Resistance and Obesity among Women 
at High Risk for Breast Cancer using Cluster Analysis 
124 
 
1. What is the woman’s age? (ALL) 
 
2. How many of the woman’s FDR-mother, sisters, daughters, 
father or sons have been diagnosed with breast cancer? 
(ALL) 
 
3. How many of the woman’s SDR- grand parents, grand 
children, aunt, uncle, niece or nephew have been 
diagnosed with breast cancer? (CL, BR, CT, BO, F, GI, EV) 
 
4. How many of the woman’s TDR have been diagnosed 
with breast cancer? (BO, GI, EV) 
 
5. If your relatives have had breast cancer, what was the 
age of onset of the disease ? (CL, BR, CT, BO, F, GI, EV) 
a. Age of onset - <55 (Co) 
b. Age of onset - <50 (FR) 
6. Have any of your relatives been diagnosed with bilateral 
breast cancer? (BR, CT, BO, F, SE, FR) 
a. Bilateral/multifocal breast tumors (GI, EV) 
 
7. Have any of your relatives been diagnosed with ovarian 
cancer? (BR, CT, BO, F, SE, FR, GI, EV) 
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8. Have any of your male relatives been diagnosed with 
breast cancer? (BR, BO, F, GI, EV) 
 
9. Have any of your relatives been diagnosed with both 
breast and ovarian cancer? (FR, GI, SE, Co) 
 
10.  Have any of your relatives been diagnosed with 
prostate cancer? (GI, EV) 
a. Colon cancer (GI) 
b. Pancreatic cancer (EV) 
 
11.  How old were you when you had your firs menstrual 
period? (G, CT, RC) 
 
12.  How old were you when you first gave birth? (G, CT) 
 
13. How old were you when your menstrual periods 
stopped (menopause)? (RC, CT) 
14. Why did your menstrual periods stop? (RC) 
 
a. Natural menopause 
b. Surgery 
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15. Have you ever taken hormone replacement 
therapy? (CT, RCS) 
 
16. Has a physician ever removed tissue from your breast 
(breast biopsy)? (C, GT) 
17.   Have you ever been diagnosed with any other 
breast diseases- atypical ductal hyperplasia? (G, CT) 
a. Lobular carcinoma in situ (CT) 
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QUESTIONNAIRE FOR BREAST CANCER RISK PREDICTION 
 
I.  BASED ON PERSONAL HISTORY 
 
1.  How old were you when you had your first menstrual 
period? 
□ > 12 
□ < 12 
 
2.  a.  Are you still having periods? 
  □ Yes (Pre-menopausal stage) 
  □ No  (Post-menopausal stage) 
 
     b.  Age of menopause? 
  □ > 45 
  □ < 44 
 
3.  a. How old were you when you first gave birth? 
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  □ >  30 
  □ < 29 
  □    No children 
 
    b. How many times have you given birth? 
  □ 1 
  □ > 2 
    c.  Duration of  breast feeding 
  □ upto 6 months 
  □ > 6 months 
 
4.  Did you experience any of the following during your 
pregnancy period? 
  □ Frequency of nausea/ vomiting 
  □ Induced abortion 
  □ Spontaneous abortion 
  □ Premature birth 
  □ Gestational diabetes mellitus 
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  □ Excessive abnormal weight gain 
  □ Pre-eclampsia 
  □ Increased birth-weight 
 
5.  Any previous exposure to radiation? 
  □ Yes 
  □ No 
    a.  Cause of exposure : X-ray - □ 
    b. How many times?   □ 
 
6.  Have you ever had any other types of cancer? 
  □ Ovarian cancer 
  □ Pancreatic cancer 
  □ Atypical Ductal Hyperplasia 
  □ Atypical Lobular Hyperplasia 
  □ Lobular Carcinoma in Situ 
 
7. What is the nature of your job? 
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  □ Chemical industry 
  □ Laboratories 
  □ others. Please mention _________ 
 
II.  BASED ON FAMILY HISTORY 
 
1.  Are you adopted? 
  □ Yes 
  □ No 
 
2. Have any of your blood relatives been diagnosed with 
breast cancer? 
  □ No 
  □ Mother 
  □ Sisters 
  □ Daughters 
  □ Aunt 
  □ Grandmothers 
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  □ Others.  Please mention  ____________. 
 
 
 
3. Have any of your blood relatives been diagnosed with 
ovarian cancer? 
  □ No 
  □ Mother 
  □ Sisters 
  □ Daughters 
  □ Aunt 
  □ Grandmothers 
  □ Others.  Please mention  ____________. 
 
4. Have you observed any common genetic defects 
among your family members? 
  □ Deaf 
  □ Blind 
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  □ Dumb 
  □ Colour blindness 
  □ Other defects. Please mention ________. 
 
III.  BASED ON MEASURABLE PARAMETERS 
 
1.  What is your height? 
     _____ m. 
 
2.  What is your body weight? 
    ______ kg. 
 
3. What is your wrist circumference? 
  ______ cm 
 
4. What is your forearm circumference? 
  _____ cm 
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5. What is your waist circumference? 
  _____ cm 
 
6. What is your hip circumference? 
  _____ cm 
 
Body Mass Index  ______. 
Body Fat Mass  ______. 
 □ High risk-overweight/obese 
 □ Normal 
 □ Underweight 
 
 
 
 
 
 
IV. BASED ON HORMONE DOMINANCE SYMPTOMS 
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SYMPTOMS E T DHEA P SHBG 
Acne   T D  S 
Anxiety  T  P  
Bloating E     
Bone loss    P  
Breast cyst E     
Cold hands and feet E     
Cyclical headaches    P  
Depression E     
Dry eyes E     
Early miscarriage    P  
Elevated insulin     S 
Elevated triglycerides  T    
Excess facial hair  T    
Fatigue E   P  
Fibrocystic breasts    P  
Fibroids    P  
Fluid retention    P  
Greasy hair   D   
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Greasy skin   D   
Hair growth on face 
and abdomen   D   
Hair loss E   P  
Heavy menstruation E     
Hirsutism     S 
Increased blood clot E     
Inferility E T  P  
Insomnia    P  
Irritability E T  P  
Joint pain    P  
Loss of scalp hair  T    
Loss of Zn E     
Low body temperature    P  
Low libido E     
Low total cholesterol E     
Menstrual cramps E   P  
Mid-cycle pain  T    
Mood swings E     
Nausea E     
Nervous  E T    
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Oily skin  T    
Ovarian cysts  T  P  
Poor sleep patterns E     
Retention of Cu E     
Sleep disturbances  T    
Sugar cravings E     
Thinning hair on head  T    
Torn, weak or relaxed 
ligaments E     
Unstable blood sugar  T    
Vaginal dryness    P  
Weight gain E    S 
Weight gain around 
abdomen    P  
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VI. BASED ON HORMONE LEVELS 
 
HORMONE CUTOFF POINTS 
(MORE THAN) S.NO PARAMETERS 
BMI  BFM 
1 T 126 132.1 
2 FT 4.6 4.1 
3 T/SHBG 2.9 2.66 
4 E1 x E2 240.62 120.06 
5 E2 x FE2 2.968 0.812 
6 
SHBG/E2 (less 
than) 
4.094 8.57 
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5 E2 x FE2 2.968 0.812 
6 
SHBG/E2 (less 
than) 
4.094 8.57 
 
VI. MAMMOGRAM SCREENING 
 
The findings of different questionnaire are pooled together 
along with mammogram findings and then evaluated 
with appropriate weightage to the factors, and then the 
risk for breast cancer can be predicted.  We hope that 
this can be extended for mass screening and 
identification of obese post-menopausal women at high 
risk for breast cancer.  
 
 
 
 
 
 
 
 
Results and Discussion 
 
A Study on Insulin Resistance and Obesity among Women 
at High Risk for Breast Cancer using Cluster Analysis 
139 
 
CONCLUSION 
 
Obesity is a chronic disease which has spread all 
over the world and threatens public global health. 
 
Obesity in postmenopausal women was highly 
correlated with several disorders including type 2 diabetes 
mellitus, hypertension, coronary heart disease, arthritis, 
sleep apnea, and certain forms of obesity-related 
cancers, including breast, prostate, endometrium, colon 
and gallbladder cancer.  However, defining an individual 
as overweight/obese using widely employed markers is a 
complex task.  Cut-off points of these markers widely vary 
among the different sections of women population.  In 
order to define obesity on a local level we stratified the 
female population based on their anthropometric 
measures using cluster analysis.  We also clustered them 
based on their body fat distribution.  Thus, we could 
identify through an alternative approach, the obese 
women who may be at high risk for breast cancer. 
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Insulin resistance (IR) is increasingly being recognized 
as an important pathophysiological determinant of not 
only diabetes but also a number of other clinical states.  
We carried out oral glucose tolerance test (OGTT-
glucose/insulin) with 29 healthy female individuals for exploring 
relationship between surrogate markers of insulin resistance 
and demographic parameters (BMI, BW, age). We also 
attempted to demonstrate the hyperbolic relationship 
between insulin sensitivity and β-cell responsitivity.  
  
 On analyzing the association between adiposity 
(using body mass index (BMI) and body fat mass (BFM)) 
and concentrations of estrogens, androgens and sex 
hormone-binding globulin we identified the hormonal 
parameters that are significantly altered in obese breast 
cancer patients.  Thus, these biomarkers may be useful for 
weight loss intervention in women with breast cancer. 
  
 Since breast cancer is the most common form of 
cancer affecting women a comprehensive questionnaire 
was built using several variables and the symptoms 
associated with hormonal variations in the disease.  We 
have attempted to include all the known risk factors 
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(personal history, family history and other measurable 
parameters) in a single questionnaire in order to predict 
the risk of breast cancer with an emphasis on hormone 
based screening.   
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